<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/atom10full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><feed xmlns="http://www.w3.org/2005/Atom" xmlns:openSearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:blogger="http://schemas.google.com/blogger/2008" xmlns:georss="http://www.georss.org/georss" xmlns:gd="http://schemas.google.com/g/2005" xmlns:thr="http://purl.org/syndication/thread/1.0" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" gd:etag="W/&quot;A0MARHY-eSp7ImA9WhBaE04.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997</id><updated>2013-05-23T16:04:05.851-04:00</updated><category term="Social Media" /><category term="Immunotherapy" /><category term="Probiotics" /><category term="Research" /><category term="Patient Perspective" /><category term="Mold" /><category term="Sleep disorders" /><category term="Insects" /><category term="Obesity" /><category term="Peanut Allergy" /><category term="Animals" /><category term="Eczema" /><category term="Omalizumab" /><category term="Medications" /><category term="JACI" /><category term="FDA" /><category term="PIDD" /><category term="ACAAI" /><category term="Exercise-induced" /><category term="T regs" /><category term="PFTs" /><category term="Diet" /><category term="IVIG" /><category term="Humor" /><category term="Albuterol" /><category term="Eosinophilic esophagitis" /><category term="Cough" /><category term="Infections" /><category term="Video" /><category term="Pollens" /><category term="Complement" /><category term="Calculator" /><category term="Nature" /><category term="Egg Allergy" /><category term="Pregnancy" /><category term="Urticaria" /><category term="Patient Information" /><category term="Toys" /><category term="Images" /><category term="Physical Exam" /><category term="Vitamin D" /><category term="Phototherapy" /><category term="Presentations" /><category term="Cardiology" /><category term="March" /><category term="Ask the Expert" /><category term="People" /><category term="TB" /><category term="iPhone" /><category term="Immunology" /><category term="PPD" /><category term="Angioedema" /><category term="Fish Allergy" /><category term="CD" /><category term="NHS" /><category term="Rhinitis" /><category term="Specific IgE" /><category term="Antibiotics" /><category term="Swimming" /><category term="SCID" /><category term="COLA Video Lectures" /><category term="Sport" /><category term="Pruritus" /><category term="Leukotrienes" /><category term="Indoor Allergens" /><category term="Penicillin Allergy" /><category term="Podcast" /><category term="Review" /><category term="Photos" /><category term="Salbutamol" /><category term="Wheezing" /><category term="Sinus Rinse" /><category term="Statins" /><category term="LTRA" /><category term="Sesame Allergy" /><category term="Endocrinology" /><category term="Patch Test" /><category term="Immunizations" /><category term="Psychology" /><category term="Drug Allergy" /><category term="Audio" /><category term="WAO" /><category term="Dog Allergy" /><category term="Links" /><category term="Tuberculosis" /><category term="BMJ" /><category term="WSAAI" /><category term="Mind Maps" /><category term="Spirometry" /><category term="School" /><category term="Smell" /><category term="Conjunctivitis" /><category term="Oral allergy syndrome" /><category term="SCIG" /><category term="Pediatrics" /><category term="ImmunoCAP" /><category term="Venom Allergy" /><category term="Mouse allergy" /><category term="Creighton University" /><category term="Fungi" /><category term="Profilin" /><category term="Food Allergy" /><category term="Atopic Dermatitis" /><category term="ICS" /><category term="EAACI" /><category term="SABAs" /><category term="Singulair" /><category term="Theophylline" /><category term="Montelukast" /><category term="Conferences" /><category term="Children" /><category term="Practice" /><category term="Vaccines" /><category term="Flickr" /><category term="Inhalers" /><category term="Tools" /><category term="HAE" /><category term="T cells" /><category term="CDC" /><category term="SMART" /><category term="Fellowship" /><category term="Avoidance" /><category term="Tax 11" /><category term="NKT cells" /><category term="Air Pollution" /><category term="Nose Spray" /><category term="Surgery" /><category term="COPD" /><category term="Immunoglobulin Therapy" /><category term="Xopenex" /><category term="Dust Mite" /><category term="Thyroid" /><category term="Genetics" /><category term="Tax 10" /><category term="Complementary Medicine" /><category term="Immunodeficiency" /><category term="NEJM" /><category term="Apps" /><category term="Travel" /><category term="EpiPen" /><category term="LABA" /><category term="Career" /><category term="History" /><category term="Journals" /><category term="SLIT" /><category term="Asthma" /><category term="Cytokines" /><category term="Costco" /><category term="Epidemiology" /><category term="Tree Nuts" /><category term="CVID" /><category term="Latex" /><category term="IgE" /><category term="Alternative Medicine" /><category term="Vocal cord dysfunction" /><category term="Oral Food Challenge" /><category term="Wheat Allergy" /><category term="Autoimmune" /><category term="Chemokines" /><category term="Aspirin" /><category term="Prevention" /><category term="Mnemonics" /><category term="Cold Urticaria" /><category term="Education" /><category term="Anaphylaxis" /><category term="Media" /><category term="Nasal Polyps" /><category term="CSACI" /><category term="Antihistamines" /><category term="Interleukins" /><category term="Twitter" /><category term="Rhinoscopy" /><category term="Clinical Cases" /><category term="Levalbuterol" /><category term="Milk Allergy" /><category term="Dermatitis" /><category term="Nickel" /><category term="GERD" /><category term="Cat Allergy" /><category term="Rodent allergy" /><category term="Occupational Asthma" /><category term="Oral Immunotherapy" /><category term="Cephalosporin Allergy" /><category term="Steroids" /><category term="Acupuncture" /><category term="local allergic rhinitis (LAR)" /><category term="Epinephrine" /><category term="FeNO" /><category term="Cockroach" /><category term="AAAAI" /><category term="Gluten" /><category term="Smoking" /><category term="Itch" /><category term="Drug Trials" /><category term="LAMA" /><category term="Chocolate" /><category term="Soy Allergy" /><category term="Contact Dermatitis" /><category term="Internet" /><category term="Birch" /><category term="Pets" /><category term="Eosinophilia" /><category term="Hygiene hypothesis" /><category term="Music" /><category term="Sinusitis" /><category term="Desensitization" /><category term="Rash" /><category term="Intranasal Steroids (INS)" /><category term="News of the Day" /><category term="Skin Testing" /><category term="Seafood" /><category term="Celiac Disease" /><category term="Black Box Warning" /><category term="SCIT" /><category term="iPad" /><category term="HyperIgE" /><category term="Nasal Irrigation" /><category term="Mayo Clinic" /><category term="Shellfish" /><title>Allergy Notes</title><subtitle type="html">&lt;center&gt;Allergy, Asthma and Immunology News Updated Daily by Board-certified Allergists and Assistant Professors at University of Chicago and NSU&lt;/center&gt;</subtitle><link rel="http://schemas.google.com/g/2005#feed" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/posts/default" /><link rel="alternate" type="text/html" href="http://allergynotes.blogspot.com/" /><link rel="next" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default?start-index=26&amp;max-results=25&amp;redirect=false&amp;v=2" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><generator version="7.00" uri="http://www.blogger.com">Blogger</generator><openSearch:totalResults>1430</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>25</openSearch:itemsPerPage><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/atom+xml" href="http://feeds.feedburner.com/AllergyNotes" /><feedburner:info uri="allergynotes" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>AllergyNotes</feedburner:emailServiceId><feedburner:feedburnerHostname>http://feedburner.google.com</feedburner:feedburnerHostname><feedburner:feedFlare href="http://add.my.yahoo.com/rss?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://us.i1.yimg.com/us.yimg.com/i/us/my/addtomyyahoo4.gif">Subscribe with My Yahoo!</feedburner:feedFlare><feedburner:feedFlare href="http://www.newsgator.com/ngs/subscriber/subext.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://www.newsgator.com/images/ngsub1.gif">Subscribe with NewsGator</feedburner:feedFlare><feedburner:feedFlare href="http://feeds.my.aol.com/add.jsp?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://o.aolcdn.com/favorites.my.aol.com/webmaster/ffclient/webroot/locale/en-US/images/myAOLButtonSmall.gif">Subscribe with My AOL</feedburner:feedFlare><feedburner:feedFlare href="http://www.bloglines.com/sub/http://feeds.feedburner.com/AllergyNotes" src="http://www.bloglines.com/images/sub_modern11.gif">Subscribe with Bloglines</feedburner:feedFlare><feedburner:feedFlare href="http://www.netvibes.com/subscribe.php?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://www.netvibes.com/img/add2netvibes.gif">Subscribe with Netvibes</feedburner:feedFlare><feedburner:feedFlare href="http://fusion.google.com/add?feedurl=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://buttons.googlesyndication.com/fusion/add.gif">Subscribe with Google</feedburner:feedFlare><feedburner:feedFlare href="http://www.pageflakes.com/subscribe.aspx?url=http%3A%2F%2Ffeeds.feedburner.com%2FAllergyNotes" src="http://www.pageflakes.com/ImageFile.ashx?instanceId=Static_4&amp;fileName=ATP_blu_91x17.gif">Subscribe with Pageflakes</feedburner:feedFlare><entry gd:etag="W/&quot;DUEFRX05fCp7ImA9WhBaEk8.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-4522464732933997842</id><published>2013-05-22T09:00:00.000-04:00</published><updated>2013-05-22T09:00:14.324-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-05-22T09:00:14.324-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Drug Allergy" /><title>Hypersensitivity reactions to paracetamol (acetaminophen, Tylenol) appear to be increasing </title><content type="html">&lt;iframe align="left" frameborder="0" marginheight="0" marginwidth="0" scrolling="no" src="http://rcm.amazon.com/e/cm?t=clicasandimab-20&amp;amp;o=1&amp;amp;p=8&amp;amp;l=bpl&amp;amp;asins=B003BDUBRA&amp;amp;fc1=000000&amp;amp;IS2=1&amp;amp;lt1=_blank&amp;amp;m=amazon&amp;amp;lc1=0000FF&amp;amp;bc1=000000&amp;amp;bg1=FFFFFF&amp;amp;f=ifr" style="align: left; height: 245px; padding-right: 10px; padding-top: 5px; width: 131px;"&gt;&lt;/iframe&gt;Hypersensitivity reactions to paracetamol (acetaminophen, Tylenol) appear to be increasing, but there are few prevalence data. &lt;br /&gt;
&lt;br /&gt;
&lt;a href="http://goo.gl/zZp9q" target="_blank"&gt;This study&lt;/a&gt; included 32 patients with suspected paracetamol allergy who underwent skin tests and an oral challenge.&lt;br /&gt;
&lt;br /&gt;
Patients presented with a combination of urticaria, angioedema (face, hands), erythema (cutaneous features in 94%), dyspnea (including laryngeal edema), rhinoconjunctivitis, cough, abdominal pain and anaphylaxis. &lt;br /&gt;
&lt;br /&gt;
Only 2 patients had a positive skin prick test (SPT) and unequivocal history of acute urticaria/facial angioedema/conjunctivitis/cough after paracetamol. One patient had a positive intradermal test. &lt;br /&gt;
&lt;br /&gt;
Oral challenge was positive in 15 of 31 patients (including self-challenge in 4). &lt;br /&gt;
&lt;br /&gt;
Overall, paracetamol hypersensitivity was confirmed in 50% patients.&lt;br /&gt;
&lt;br /&gt;
75% of paracetamol-allergic patients tolerated NSAIDs. 25% were intolerant of NSAIDs. &lt;br /&gt;
&lt;br /&gt;
Specific IgE may be a mechanism underlying paracetamol hypersensitivity in some patients. In 81% of patients, negative skin tests did not exclude paracetamol hypersensitivity, suggesting that it may be mediated by leukotrienes. &lt;br /&gt;
&lt;br /&gt;
The authors suggested that in suspected paracetamol allergy, skin tests should be performed along with oral challenge.&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;
&lt;br /&gt;
Paracetamol Hypersensitivity: Clinical Features, Mechanism and Role of Specific IgE. Rutkowski K, Nasser SM, Ewan PW. Int Arch Allergy Immunol. 2012 May 3;159(1):60-64.&lt;br /&gt;
&lt;a href="http://goo.gl/zZp9q"&gt;http://goo.gl/zZp9q&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://plus.google.com/u/0/110859855629071891085/posts/P3ZCRNFVs1B"&gt;Comments from Google Plus&lt;/a&gt;:&lt;br /&gt;
&lt;br /&gt;
Ahmad Gandour: This study only included 32 we need a larger study ?﻿&lt;br /&gt;
&lt;br /&gt;
Boyan Hadjiev: Better 32 than just case reports. This type of study takes lots of time and energy. The makers of Tylenol would certainly NOT sponsor it (or so I am inclined to believe). I say kudos to the researchers. Still if you look at results, you can't rely on ANY skin tests to predict outcome at all!!! Sounds like oral challenge is the only way, and it was positive in 50% of patients. That's pretty low.﻿&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/Bf-oHdjLK6k" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/4522464732933997842/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/05/hypersensitivity-reactions-to.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4522464732933997842?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4522464732933997842?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/Bf-oHdjLK6k/hypersensitivity-reactions-to.html" title="Hypersensitivity reactions to paracetamol (acetaminophen, Tylenol) appear to be increasing " /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/05/hypersensitivity-reactions-to.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CUcEQ3w4eSp7ImA9WhBaEEg.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-2023416845914255419</id><published>2013-05-20T08:30:00.000-04:00</published><updated>2013-05-20T08:30:02.231-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-05-20T08:30:02.231-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Atopic Dermatitis" /><category scheme="http://www.blogger.com/atom/ns#" term="Food Allergy" /><title>Atopic dermatitis associated with food allergy accelerates progression of allergic march</title><content type="html">Studies demonstrate the comorbidity of food allergy (FA) and allergic march. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/23267210?dopt=Abstract" target="_blank"&gt;This study&lt;/a&gt; assessed prevalence and comorbidity of allergic diseases in 3,000 Japanese students.&lt;br /&gt;
&lt;br /&gt;
The lifetime prevalence of allergic rhinitis (AR), atopic dermatitis (AD), bronchial asthma (BA), and FA was 36%, 16%, 10%, and 7%, respectively.&lt;br /&gt;
&lt;br /&gt;
Comorbidity with AD lowered the onset age of both BA and AR. Comorbidity with FA was the highest risk factor for the progression of allergic march.&lt;br /&gt;
&lt;br /&gt;
AD associated with FA accelerates the subsequent progression of allergic march. &lt;br /&gt;
&lt;br /&gt;
Allergic (atopic) march (click&amp;nbsp;&lt;a href="https://docs.google.com/drawings/d/1OgBFJKwtRbeKjXTV-Tt4xUQATpCq7hXSrgNIy_s_ntw/edit?hl=en_US"&gt;here to enlarge the image&lt;/a&gt;): &lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=1OgBFJKwtRbeKjXTV-Tt4xUQATpCq7hXSrgNIy_s_ntw&amp;amp;w=480&amp;amp;h=360" /&gt;&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/23267210?dopt=Abstract" target="_blank"&gt;Prevalence and impact of past history of food allergy in atopic dermatitis&lt;/a&gt;. Kijima A, Murota H, Takahashi A, Arase N, Yang L, Nishioka M, Yamaoka T, Kitaba S, Yamauchi-Takihara K, Katayama I.&amp;nbsp;Allergol Int. 2013 Mar;62(1):105-12. doi: 10.2332/allergolint.12-OA-0468. Epub 2012 Dec 25.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/gl6qSCwIFlk" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/2023416845914255419/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/05/atopic-dermatitis-associated-with-food.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2023416845914255419?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2023416845914255419?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/gl6qSCwIFlk/atopic-dermatitis-associated-with-food.html" title="Atopic dermatitis associated with food allergy accelerates progression of allergic march" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/05/atopic-dermatitis-associated-with-food.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CEcBQXo9eip7ImA9WhBbFUU.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-4515865766599436872</id><published>2013-05-14T08:30:00.000-04:00</published><updated>2013-05-14T21:40:50.462-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-05-14T21:40:50.462-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Seafood" /><category scheme="http://www.blogger.com/atom/ns#" term="Fish Allergy" /><category scheme="http://www.blogger.com/atom/ns#" term="Shellfish" /><category scheme="http://www.blogger.com/atom/ns#" term="Food Allergy" /><title>Cross-reacting allergens between fish, shellfish, arachnids, and insects</title><content type="html">&lt;a href="http://upload.wikimedia.org/wikipedia/commons/thumb/a/a3/Atlantic_cod.jpg/180px-Atlantic_cod.jpg"&gt;&lt;img alt="" border="0" src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/a3/Atlantic_cod.jpg/180px-Atlantic_cod.jpg" style="cursor: pointer; float: right; height: 77px; margin: 0pt 0pt 10px 10px; width: 180px;" /&gt;&lt;/a&gt;The increased consumption of fish and shellfish has resulted in more frequent reports of adverse reactions to seafood. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Cross-reactivity is a problem&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Potential cross-reacting allergens have been identified within the fish family and between shellfish, arachnids, and insects. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Prick-to-prick tests may be needed&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
The diagnostic approach may require prick-to-prick tests using crude extracts of both raw and cooked forms of seafood for screening seafood sensitization. This approach may be required before a food challenge or where food challenge is not feasible. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Different epitopes may explain different disease severity&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
IgE antibodies from individuals with persistent allergy may be directed against different epitopes than those in patients with transient allergy. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Mutated proteins as future immunotherapy&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Mutated less allergenic seafood proteins have been developed for allergen-specific immunotherapy but this approach is still experimental and not ready for prime time.&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;
&lt;br /&gt;
Fish and shellfish allergy in children: Review of a persistent food allergy. Tsabouri S, Triga M, Makris M, Kalogeromitros D, Church MK, Priftis KN. Pediatr Allergy Immunol. 2012 May 3. doi: 10.1111/j.1399-3038.2012.01275.x. [Epub ahead of print]&lt;br /&gt;
&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/22554093?dopt=Abstract"&gt;http://www.ncbi.nlm.nih.gov/pubmed/22554093?dopt=Abstract&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
Image source: Gadus morhua, Atlantic cod.&amp;nbsp;&lt;a href="http://en.wikipedia.org/wiki/File:Atlantic_cod.jpg" rel="nofollow" target="_blank"&gt;Wikipedia&lt;/a&gt;, public domain.&lt;br /&gt;
&lt;br /&gt;
Comments from Twitter:&lt;br /&gt;
&lt;br /&gt;
Dr. Ellis @DrAnneEllis: Crustaceans are the "bugs of the sea"&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/1NeUxyaNaVo" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/4515865766599436872/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/05/cross-reacting-allergens-between-fish.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4515865766599436872?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4515865766599436872?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/1NeUxyaNaVo/cross-reacting-allergens-between-fish.html" title="Cross-reacting allergens between fish, shellfish, arachnids, and insects" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/05/cross-reacting-allergens-between-fish.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C0ECRH0yfSp7ImA9WhBbFEU.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-1228733243535050538</id><published>2013-05-13T09:30:00.000-04:00</published><updated>2013-05-13T17:47:45.395-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-05-13T17:47:45.395-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><title>Prescribing inhaled steroid during ED visit for asthma decreases admissions, saves $7k per 100 patients</title><content type="html">&lt;a href="http://2.bp.blogspot.com/_LY7APi0bufs/RnEwrofMZhI/AAAAAAAABY4/HpJnDsaKWtw/s1600-h/470px-Asthma_before-after.jpg"&gt;&lt;img alt="" border="0" id="BLOGGER_PHOTO_ID_5075891781184022034" src="http://2.bp.blogspot.com/_LY7APi0bufs/RnEwrofMZhI/AAAAAAAABY4/HpJnDsaKWtw/s200/470px-Asthma_before-after.jpg" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;&lt;a href="http://www.jpeds.com/article/PIIS002234761200532X/abstract" target="_blank"&gt;This  cost-effectiveness analysis&lt;/a&gt; compared 3 ED-based inhaled corticosteroid (ICS) delivery options: &lt;br /&gt;
&lt;br /&gt;
- usual care (recommending outpatient follow-up)&lt;br /&gt;
- prescribe (uniformly prescribing ICS)&lt;br /&gt;
- dispense (uniformly dispensing ICS)&lt;br /&gt;
&lt;br /&gt;
Rates of ED relapse visits and hospitalizations within 1 month of ED visit were compared across all 3 arms. &lt;br /&gt;
&lt;br /&gt;
Rate of return to ED per 100 patients within 1 month of the ED visit was 10 visits for the usual care arm, 9 visits for the prescription arm, and 8 visits for the medication-dispensing arm. Rates of hospitalization per 100 patients were 2.4, 2.2, and 1.9, respectively. &lt;br /&gt;
&lt;br /&gt;
Including indirect costs related to missed parental work, total costs per 100 patients were $27,100, $22,000, and $20,100, respectively. Total cost savings per 100 patients comparing the usual care arm with the medication dispensing arm was $7000.&lt;br /&gt;
&lt;br /&gt;
This study suggests that uniform prescribing or dispensing of ICS at the time of ED visit for asthma may lead to a decreased number of ED visits and hospital admissions within 1 month and provides substantial cost-savings.&lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=19kjzClqEQ3gQjHfZ27ImlrrucJp9uE7yRdIT554buPI&amp;amp;w=476&amp;amp;h=346" /&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/drawings/edit?id=19kjzClqEQ3gQjHfZ27ImlrrucJp9uE7yRdIT554buPI&amp;amp;hl=en"&gt;Asthma Inhalers&lt;/a&gt; (click to enlarge the image).&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;
&lt;br /&gt;
A Cost-Effectiveness Analysis of Inhaled Corticosteroid Delivery for Children with Asthma in the Emergency Department. Annie Lintzenich Andrews, et al. The Journal of Pediatrics, Volume 161, Issue 5 , Pages 903-907.e1, November 2012&lt;br /&gt;
&lt;a href="http://www.jpeds.com/article/PIIS002234761200532X/abstract"&gt;http://www.jpeds.com/article/PIIS002234761200532X/abstract&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
Image source: Image source: FDA and Wikipedia,&amp;nbsp;&lt;a href="http://en.wikipedia.org/wiki/Image:Asthma_before-after.png" rel="nofollow" target="_blank"&gt;public domain&lt;/a&gt;.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/6kUHmUBOvqU" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/1228733243535050538/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/05/prescribing-inhaled-steroid-during-ed.html#comment-form" title="1 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1228733243535050538?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1228733243535050538?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/6kUHmUBOvqU/prescribing-inhaled-steroid-during-ed.html" title="Prescribing inhaled steroid during ED visit for asthma decreases admissions, saves $7k per 100 patients" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://2.bp.blogspot.com/_LY7APi0bufs/RnEwrofMZhI/AAAAAAAABY4/HpJnDsaKWtw/s72-c/470px-Asthma_before-after.jpg" height="72" width="72" /><thr:total>1</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/05/prescribing-inhaled-steroid-during-ed.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C0UDRnoyeCp7ImA9WhBbEU8.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-1757633531205331940</id><published>2013-05-09T09:00:00.000-04:00</published><updated>2013-05-09T13:41:17.490-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-05-09T13:41:17.490-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Epinephrine" /><category scheme="http://www.blogger.com/atom/ns#" term="Anaphylaxis" /><category scheme="http://www.blogger.com/atom/ns#" term="Food Allergy" /><title>Auvi-Q inventors -- twins with food allergies -- profiled by CNN</title><content type="html">&lt;object classid="clsid:D27CDB6E-AE6D-11cf-96B8-444553540000" height="234" id="ep_1470" width="416"&gt;&lt;param name="allowfullscreen" value="true" /&gt;&lt;param name="allowscriptaccess" value="always" /&gt;&lt;param name="wmode" value="transparent" /&gt;&lt;param name="movie" value="http://i.cdn.turner.com/cnn/.element/apps/cvp/3.0/swf/cnn_embed_2x_container.swf?site=cnn&amp;profile=desktop&amp;context=embedwww&amp;videoId=health/2013/05/08/gupta-human-factor-eric-and-evan-edwards.cnn&amp;contentId=health/2013/05/08/gupta-human-factor-eric-and-evan-edwards.cnn" /&gt;&lt;param name="bgcolor" value="#000000" /&gt;&lt;embed src="http://i.cdn.turner.com/cnn/.element/apps/cvp/3.0/swf/cnn_embed_2x_container.swf?site=cnn&amp;profile=desktop&amp;context=embedwww&amp;videoId=health/2013/05/08/gupta-human-factor-eric-and-evan-edwards.cnn&amp;contentId=health/2013/05/08/gupta-human-factor-eric-and-evan-edwards.cnn" type="application/x-shockwave-flash" bgcolor="#000000" allowfullscreen="true" allowscriptaccess="always" width="416" wmode="transparent" height="234"&gt;&lt;/embed&gt;&lt;/object&gt;    &lt;p&gt;&lt;p/&gt;From &lt;a href="http://bit.ly/10HKplg" target="_blank"&gt;CNN&lt;/a&gt;: &lt;p&gt;&lt;p/&gt;Evan and Eric Edwards have life-threatening allergies and wanted to develop a better way to deliver epinephrine, a drug used to treat serious allergic reactions. Their vision started shortly after graduating from high school and became a reality 15 years later.  About a month after Auvi-Q's launch, a mother described how her daughter had a severe allergic reaction. She described how Auvi-Q helped her by "having a voice walking through the steps in an emergency situation." In her opinion, Auvi-Q saved her daughter's life.    &lt;p&gt;&lt;p/&gt;References:  Twins create life-saving allergy device - CNN.com &lt;a href="http://bit.ly/10HKplg"&gt;http://bit.ly/10HKplg&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/fq0VqFikxPo" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/1757633531205331940/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/05/auvi-q-inventors-twins-with-food.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1757633531205331940?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1757633531205331940?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/fq0VqFikxPo/auvi-q-inventors-twins-with-food.html" title="Auvi-Q inventors -- twins with food allergies -- profiled by CNN" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/05/auvi-q-inventors-twins-with-food.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CEEGQno-fCp7ImA9WhBbEE4.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-3665438253466690026</id><published>2013-05-08T13:03:00.005-04:00</published><updated>2013-05-08T13:03:43.454-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-05-08T13:03:43.454-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><category scheme="http://www.blogger.com/atom/ns#" term="Video" /><category scheme="http://www.blogger.com/atom/ns#" term="Patient Information" /><category scheme="http://www.blogger.com/atom/ns#" term="Inhalers" /><category scheme="http://www.blogger.com/atom/ns#" term="CDC" /><title>How to use a metered dose inhaler (MDI) - CDC teaching videos</title><content type="html">Using a metered dose inhaler with a spacer: &lt;br /&gt;
&lt;br /&gt;
&lt;iframe width="420" height="315" src="http://www.youtube.com/embed/BbONuRXJdr0?rel=0" frameborder="0" allowfullscreen&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
Using a metered dose inhaler (inhaler in mouth): &lt;br /&gt;
&lt;br /&gt;
&lt;iframe width="420" height="315" src="http://www.youtube.com/embed/Lx_e5nXfi5w?rel=0" frameborder="0" allowfullscreen&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
Using a metered dose inhaler one to two inches from mouth: &lt;br /&gt;
&lt;br /&gt;
&lt;iframe width="420" height="315" src="http://www.youtube.com/embed/nmvhFSnlRGE?rel=0" frameborder="0" allowfullscreen&gt;&lt;/iframe&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/CJzI5tQuw-s" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/3665438253466690026/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/05/how-to-use-metered-dose-inhaler-mdi-cdc.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3665438253466690026?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3665438253466690026?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/CJzI5tQuw-s/how-to-use-metered-dose-inhaler-mdi-cdc.html" title="How to use a metered dose inhaler (MDI) - CDC teaching videos" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://img.youtube.com/vi/BbONuRXJdr0/default.jpg" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/05/how-to-use-metered-dose-inhaler-mdi-cdc.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DEQDSHw_eSp7ImA9WhBUF0w.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8160390753438895377</id><published>2013-05-03T08:30:00.000-04:00</published><updated>2013-05-04T21:12:59.241-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-05-04T21:12:59.241-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><category scheme="http://www.blogger.com/atom/ns#" term="Steroids" /><category scheme="http://www.blogger.com/atom/ns#" term="Inhalers" /><category scheme="http://www.blogger.com/atom/ns#" term="ICS" /><title>Inhaled steroids at high doses may cause adrenal insufficiency </title><content type="html">Adrenal insufficiency is a potential complication of therapy with inhaled corticosteroids (ICS). Previous studies found the highest risk of adrenal insufficiency with fluticasone. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/23060630" target="_blank"&gt;This study&lt;/a&gt; reexamined the relationship between the use of ICS and adrenal insufficiency by using a cohort of patients treated for respiratory conditions during 1990-2005 in Quebec, Canada, with follow-up until 2007. &lt;br /&gt;
&lt;br /&gt;
Cases of adrenal insufficiency were matched with up to 10 controls. 392 cases were identified (incidence rate=1/10,000 person-years). The rate of adrenal insufficiency was not significantly higher among all current users of ICS. However, &lt;b&gt;patients receiving the highest dosages showed a greater risk (OR=1.84)&lt;/b&gt;.&lt;br /&gt;
&lt;br /&gt;
Inhaled corticosteroids at high doses appear to be a significant independent risk factor for adrenal insufficiency. Physicians prescribing ICS at higher doses should be aware of the signs and symptoms of adrenal insufficiency in their patients.&lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=19kjzClqEQ3gQjHfZ27ImlrrucJp9uE7yRdIT554buPI&amp;amp;w=476&amp;amp;h=346" /&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/drawings/edit?id=19kjzClqEQ3gQjHfZ27ImlrrucJp9uE7yRdIT554buPI&amp;amp;hl=en"&gt;Asthma Inhalers&lt;/a&gt; (click to enlarge the image).&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;
&lt;br /&gt;
The use of inhaled corticosteroids and the risk of adrenal insufficiency. Lapi F, Kezouh A, Suissa S, Ernst P. Eur Respir J. 2012 Oct 11. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/23060630"&gt;http://www.ncbi.nlm.nih.gov/pubmed/23060630&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/_qIpW0rKqSc" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8160390753438895377/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/05/inhaled-steroids-at-high-doses-may-be.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8160390753438895377?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8160390753438895377?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/_qIpW0rKqSc/inhaled-steroids-at-high-doses-may-be.html" title="Inhaled steroids at high doses may cause adrenal insufficiency " /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/05/inhaled-steroids-at-high-doses-may-be.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CkMERH86fCp7ImA9WhBUEkk.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-4578006387874624396</id><published>2013-04-29T09:00:00.000-04:00</published><updated>2013-04-29T09:00:05.114-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-04-29T09:00:05.114-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><category scheme="http://www.blogger.com/atom/ns#" term="Montelukast" /><category scheme="http://www.blogger.com/atom/ns#" term="Pediatrics" /><title>No effect from montelukast on respiratory symptoms and lung function in wheezy infants</title><content type="html">&lt;a href="http://1.bp.blogspot.com/_otrvz2aDOLk/R8ioKMHuIwI/AAAAAAAAADY/La4rMyO_v24/s1600-h/250px-Singulair.png" onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}"&gt;&lt;img alt="" border="0" id="BLOGGER_PHOTO_ID_5172569065040782082" src="http://1.bp.blogspot.com/_otrvz2aDOLk/R8ioKMHuIwI/AAAAAAAAADY/La4rMyO_v24/s200/250px-Singulair.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;&lt;a href="http://erj.ersjournals.com/content/41/3/664.short" target="_blank"&gt;This study&lt;/a&gt; from Finland investigated the effectiveness of montelukast in recurrently wheezy infants and&amp;nbsp;randomized&amp;nbsp;113 children (6–24-month-old) with recurrent wheezing to receive either placebo or montelukast daily for an 8-week period. &lt;br /&gt;
&lt;br /&gt;
There was no significant difference in symptom-free days between the two groups, or the use of rescue medication, exhaled nitric oxide fraction (FeNO) or airway parameters measured by whole-body plethysmograph, squeeze technique, and methacholine challenge.&lt;br /&gt;
&lt;br /&gt;
Montelukast therapy did not influence the number of symptom-free days, use of rescue medication, or lung function in recurrently wheezy, very young children.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Not all wheezing is asthma&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Wheezing occurrences in children: &lt;br /&gt;
&lt;br /&gt;
- single episode in 30% to 50% of children before 5 yr of age&lt;br /&gt;
- 40% who wheeze before 3 yr of age continue at 6 yr (“persistent wheezers”)&lt;br /&gt;
- 50% of infants who wheeze once will wheeze again within several months&lt;br /&gt;
&lt;br /&gt;
&lt;img src="http://docs.google.com/drawings/pub?id=1Ti1DLPu2i0dKT-ljMaH6iLJwQ6-atuFbSRdOt8Tz1lw&amp;amp;w=476&amp;amp;h=346" /&gt;&lt;br /&gt;
&lt;a href="https://docs.google.com/drawings/edit?id=1Ti1DLPu2i0dKT-ljMaH6iLJwQ6-atuFbSRdOt8Tz1lw&amp;amp;hl=en"&gt;Wheezing in Children - Phenotypes&lt;/a&gt; (click to enlarge the image).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Childhood asthma phenotypes: &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
- &lt;b&gt;transient early wheezers&lt;/b&gt; - wheeze sometime during first year of life; risk factors include prematurity, history of parental smoking during pregnancy, and passive exposure to tobacco smoke; such patients do not respond to inhaled bronchodilators or inhaled corticosteroids (ICS); wheezing tends to remit as child’s airway gets larger (between ages 2-3 yr)&lt;br /&gt;
&lt;br /&gt;
- &lt;b&gt;nonatopic wheezers&lt;/b&gt; - 0 to 6 yr of age; wheeze associated exclusively with viral infection; usually no eczema or family history; wheezing tends to remit by 6 yr of age&lt;br /&gt;
&lt;br /&gt;
- &lt;b&gt;atopic wheezers&lt;/b&gt; - past 5 yr of age, allergic - have positive blood and skin testing to inhalant allergens; tend to present within 2 to 3 yr of age, and continue to wheeze; wheezing not related to URTI&lt;br /&gt;
&lt;br /&gt;
&lt;img src="http://docs.google.com/drawings/pub?id=1N_G6-zPxlOaBlsoQiPYCtN9nhUYpf2ChLCk1Pdv97z4&amp;amp;w=476&amp;amp;h=346" /&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/drawings/edit?id=1N_G6-zPxlOaBlsoQiPYCtN9nhUYpf2ChLCk1Pdv97z4&amp;amp;hl=en"&gt;Childhood asthma phenotypes&lt;/a&gt; (click to enlarge the image).&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;
&lt;br /&gt;
The effect of montelukast on respiratory symptoms and lung function in wheezy infants. Anna S. Pelkonen et al. ERJ March 1, 2013 vol. 41 no. 3 664-670.&amp;nbsp;&lt;a href="http://erj.ersjournals.com/content/41/3/664.short"&gt;http://erj.ersjournals.com/content/41/3/664.short&lt;/a&gt;&lt;br /&gt;
Image source:&amp;nbsp;&lt;a href="http://en.wikipedia.org/wiki/Image:Singulair.png" rel="nofollow" target="_blank"&gt;Montelukast&lt;/a&gt;, from Wikipedia, the free encyclopedia, public domain.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/Hp9nBnpZDh8" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/4578006387874624396/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/04/no-effect-from-montelukast-on.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4578006387874624396?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4578006387874624396?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/Hp9nBnpZDh8/no-effect-from-montelukast-on.html" title="No effect from montelukast on respiratory symptoms and lung function in wheezy infants" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/_otrvz2aDOLk/R8ioKMHuIwI/AAAAAAAAADY/La4rMyO_v24/s72-c/250px-Singulair.png" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/04/no-effect-from-montelukast-on.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C0UEQ30-fyp7ImA9WhBVGEQ.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8128264024903742417</id><published>2013-04-25T08:00:00.000-04:00</published><updated>2013-04-25T08:00:02.357-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-04-25T08:00:02.357-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><category scheme="http://www.blogger.com/atom/ns#" term="Video" /><category scheme="http://www.blogger.com/atom/ns#" term="Exercise-induced" /><title>Winning Athletes with Asthma and EIB (video)</title><content type="html">From the ACAAI Allergist channel on YouTube: The Kloser family of Colorado lives life on the edge. When competitive athletes Christian and Mike were diagnosed with asthma and exercise-induced bronchoconstriction (EIB), they refused to let it slow them down. They share their story and successful treatment from an allergist with the American College of Allergy, Asthma and Immunology (ACAAI):&lt;br /&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen="" frameborder="0" height="315" src="http://www.youtube.com/embed/HiQZ4HnX7OI?rel=0" width="560"&gt;&lt;/iframe&gt;&lt;br /&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/JFyxB9vYSec" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8128264024903742417/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/04/winning-athletes-with-asthma-and-eib.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8128264024903742417?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8128264024903742417?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/JFyxB9vYSec/winning-athletes-with-asthma-and-eib.html" title="Winning Athletes with Asthma and EIB (video)" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://img.youtube.com/vi/HiQZ4HnX7OI/default.jpg" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/04/winning-athletes-with-asthma-and-eib.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C0YAQ3o9fip7ImA9WhBVGEw.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-892354279665062183</id><published>2013-04-24T08:30:00.000-04:00</published><updated>2013-04-24T09:45:42.466-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-04-24T09:45:42.466-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Obesity" /><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><category scheme="http://www.blogger.com/atom/ns#" term="Air Pollution" /><title>Being overweight increases susceptibility to indoor pollutants among urban children with asthma </title><content type="html">&lt;a href="http://1.bp.blogspot.com/_LY7APi0bufs/RrCibh_MkGI/AAAAAAAABiM/_pkrSalc4iU/s1600-h/Obesity-waist_circumference.PNG"&gt;&lt;img alt="" border="0" id="BLOGGER_PHOTO_ID_5093749772419633250" src="http://1.bp.blogspot.com/_LY7APi0bufs/RrCibh_MkGI/AAAAAAAABiM/_pkrSalc4iU/s200/Obesity-waist_circumference.PNG" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/23403052" target="_blank"&gt;This study&lt;/a&gt; from Johns Hopkins School of Medicine (Baltimore, Md) included 148 children (age, 5-17 years) with persistent asthma that were followed for 1 year. Participants were predominantly African American (91%) and had public health insurance (85%), 16% were overweight, and 28% were obese. &lt;br /&gt;
&lt;br /&gt;
Overweight or obese participants had more symptoms associated with exposure to fine particulate matter measuring less than 2.5 μm in diameter (PM(2.5)) than normal-weight participants. They also had more asthma symptoms associated with nitrogen dioxide (NO(2)) exposure. &lt;br /&gt;
&lt;br /&gt;
However, there was no relationship with coarse particulate matter (2.5 and 10 μm) and health care use, lung function, or pulmonary inflammation.&lt;br /&gt;
&lt;br /&gt;
Being overweight or obese can increase susceptibility to indoor PM(2.5) and NO(2) in urban children with asthma. &lt;br /&gt;
&lt;br /&gt;
Interventions aimed at weight loss might reduce asthma symptom responses to PM(2.5) and NO(2). Reducing indoor pollutant levels might be beneficial in overweight children. However, the effect of these measures on lung function is not clear from this study.&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;
&lt;br /&gt;
Being overweight increases susceptibility to indoor pollutants among urban children with asthma. Lu KD, Breysse PN, Diette GB, Curtin-Brosnan J, Aloe C, Williams DL, Peng RD, McCormack MC, Matsui EC. J Allergy Clin Immunol. 2013 Feb 9. pii: S0091-6749(13)00006-7. doi: 10.1016/j.jaci.2012.12.1570. &lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/23403052"&gt;http://www.ncbi.nlm.nih.gov/pubmed/23403052&lt;/a&gt;&lt;br /&gt;Image source:&amp;nbsp;&lt;a href="http://en.wikipedia.org/wiki/Image:Obesity-waist_circumference.PNG" rel="nofollow" target="_blank"&gt;Wikipedia&lt;/a&gt;, public domain.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/VlisHhQpL-M" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/892354279665062183/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/04/being-overweight-increases.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/892354279665062183?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/892354279665062183?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/VlisHhQpL-M/being-overweight-increases.html" title="Being overweight increases susceptibility to indoor pollutants among urban children with asthma " /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/_LY7APi0bufs/RrCibh_MkGI/AAAAAAAABiM/_pkrSalc4iU/s72-c/Obesity-waist_circumference.PNG" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/04/being-overweight-increases.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C08EQXs4eip7ImA9WhBVEkQ.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8398000926829410319</id><published>2013-04-18T09:30:00.001-04:00</published><updated>2013-04-18T09:30:00.532-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-04-18T09:30:00.532-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><title>Severe asthma greatly increases the risk of pulmonary embolism (study)</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/Saphenous%20vein.jpg"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/Saphenous%20vein.jpg" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;Patients with asthma have activated coagulation within the airways which may lead to an increase in venous thromboembolic events (VTE). &lt;a href="http://erj.ersjournals.com/content/early/2012/12/19/09031936.00150312.abstract" target="_blank"&gt;This study from The Netherlands&lt;/a&gt; assessed the incidence of VTE in 648 patients with mild-moderate and severe asthma as compared to a control population.&lt;br /&gt;
&lt;br /&gt;
All patients completed a questionnaire about a diagnosis of deep-vein thrombosis (DVT) and pulmonary embolism (PE) in the past, their risk factors, history of asthma and medication use. All VTE were objectively verified.&lt;br /&gt;
&lt;br /&gt;
In total, 35 VTE events occurred at a median age of 39 years, 16 events of deep-vein thrombosis (DVT) and 19 events of pulmonary embolism (PE).&lt;br /&gt;
&lt;br /&gt;
The incidence of PE in patients with severe asthma was 0.93 (per 1000 person-years, 0.33 in mild-moderate asthma, and 0.18 in the control group, respectively. Severe asthma and oral corticosteroid use were independent risk factors of PE (hazard ratios: 3.33 and 2.82 respectively). Asthma was not associated with DVT.&lt;br /&gt;
&lt;br /&gt;
The study authors concluded that severe asthma greatly enhances the risk of pulmonary embolism, particularly if chronic corticosteroids are used.&lt;br /&gt;
&lt;br /&gt;
References:&lt;br /&gt;&lt;br /&gt;&lt;a href="http://erj.ersjournals.com/content/early/2012/12/19/09031936.00150312.abstract" rel="nofollow" target="_blank"&gt;Risk of deep-vein thrombosis and pulmonary embolism in asthma&lt;/a&gt;. Christof J. Majoor et al. ERJ December 20, 2012 erj01503-2012. &lt;br /&gt;
Image source: Saphenous vein, Gray's Anatomy, 1918 (public domain).&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/UP8vTipHz4w" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8398000926829410319/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/04/severe-asthma-greatly-increases-risk-of.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8398000926829410319?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8398000926829410319?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/UP8vTipHz4w/severe-asthma-greatly-increases-risk-of.html" title="Severe asthma greatly increases the risk of pulmonary embolism (study)" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/04/severe-asthma-greatly-increases-risk-of.html</feedburner:origLink></entry><entry gd:etag="W/&quot;A0cEQ3szeCp7ImA9WhBVEE8.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-6039957257010670490</id><published>2013-04-15T08:30:00.000-04:00</published><updated>2013-04-15T08:30:02.580-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-04-15T08:30:02.580-04:00</app:edited><title>Pro-con debate - ACOs are, or are not, good for the practicing allergist - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me. This is the last edition of the 2013 series. You can see &lt;a href="http://allergynotes.blogspot.com/search/label/AAAAI" target="_blank"&gt;the rest of summaries here&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Pro-con debate - ACOs are, or are not, good for the practicing allergist&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Daniel Ein was con, Michael Foggs was pro in ACO debate.&lt;br /&gt;
&lt;br /&gt;
Dr Ein’s Definition: ACO is a legal entity composed a group of providers that assume responsibility for management/care in an effective/efficient manner. ACOs have 2 main functions - delivery of care and administration of care. Administrative functions can be farmed out to health management organizations such as MSO.&lt;br /&gt;
&lt;br /&gt;
ACOs can include various specialists or can contract out their services. Hospitals have to be involved, at least as partners - But Incentives of hospitals are different than those of providers. 2.4 million have been enrolled in ACOs as of Nov 2012. There are 4 times more private ACOs than Medicare ACOs.&lt;br /&gt;
&lt;br /&gt;
Do ACOs reduce costs? Evidence from really only 1 study (a shared-saving program) JAMA 308:1015. Annual savings were modest ($114 per year per patient), all showed reduced hospitalizations/ED visits though. ACOs may not really be worth the substantial effort.&lt;br /&gt;
&lt;br /&gt;
Dr Foggs (pro): His group, Advocate, has been buying up numerous practices, including specialties. He says ACOs put allergists in a precarious position unless we change we'll be extinct. And he's on the pro side! Allergists need to align themselves with these large groups to save themselves and the practice of allergy.&lt;br /&gt;
&lt;br /&gt;
The 3 building blocks of the new system are ACOs, medical home and EHR. Solo or single specialty groups will be difficult in the future.&lt;br /&gt;
&lt;br /&gt;
Risks of non-participation include: further encroachment by ENT/pulmonary and less reliance of PCPs on your services.&lt;br /&gt;
&lt;br /&gt;
How to get involved - get more active in your hospital. Upsides of involvement: maintain and expand your referral base, no immediate changes in FFS.&lt;br /&gt;
&lt;br /&gt;
Merging with other allergists or forming an IPA may help maintain some independence.&lt;br /&gt;
&lt;br /&gt;
PCPs have to be involved with only one ACO, specialists can be in multiple ACOs but if a patient comes to you for most of their care and doesn't have a PCP, then you could be designated as their PCP and only eligible for one ACO.&lt;br /&gt;
&lt;br /&gt;
Dr Ein: Would u join an org that might reduce your reimbursement, that would make you share in possible losses, that might go bankrupt, that would dictate to you how to practice, what's the rush?&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/MatthewBowdish"&gt;https://twitter.com/MatthewBowdish&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/SI6ewLA5PDY" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/6039957257010670490/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/04/pro-con-debate-acos-are-or-are-not-good.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6039957257010670490?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6039957257010670490?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/SI6ewLA5PDY/pro-con-debate-acos-are-or-are-not-good.html" title="Pro-con debate - ACOs are, or are not, good for the practicing allergist - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/04/pro-con-debate-acos-are-or-are-not-good.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C0MBRHk7cCp7ImA9WhBWF04.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-28316957510091361</id><published>2013-04-10T10:51:00.002-04:00</published><updated>2013-04-11T21:50:55.708-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-04-11T21:50:55.708-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Asthma" /><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Asthma - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Asthma guidelines &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr Busse discussed some new medications/treatments that may get into the new US asthma guidelines: Anticholinergics? Bronchial thermoplasty? Step down with LABA? Intermittent steroid use? Antibiotic use? SMART Symbicort?&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;LAMA&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
LAMA, eg tiotropium, is used in COPD. A NEJM 2010 study looked at asthma. Add on therapy with LAMA was better than LABA. A NEJM 2012 study of tiotropium in poorly controlled asthma showed improvement in FEV1 and reduction in exacerbations.&lt;br /&gt;
&lt;br /&gt;
The likelihood that we will see the addition of LAMA's to the guidelines for more severe asthma is STRONG.&lt;br /&gt;
&lt;br /&gt;
Intermittent use of ICS in mild asthma will be discussed.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Asthma and allergy medications in pregnancy &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr. Namazy: intranasal budesonide is Category B in pregnancy and the INS of choice but there are no major concerns with the others.&lt;br /&gt;
&lt;br /&gt;
Loratidine and cetrizine are viewed as antihistamines of choice in US, and pseudoephedrine for decongestants.&lt;br /&gt;
&lt;br /&gt;
Meta-analysis of 6 studies of SABA in asthma showed no obvious increase in birth complications. In the past, SABA use was associated with GI defects, but it could be confounded by severity. Large scale QC data did not confirm this.&lt;br /&gt;
&lt;br /&gt;
A study of ICS found no increase in perinatal mortality (Breton JACI article). A "step down" during pregnancy for fear of side effects can cause significant complications.&lt;br /&gt;
&lt;br /&gt;
42% of pregnant women think there are teratogenic effects from OCS. It's 12% for ICS and 5% for SABA.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/IgECPD"&gt;https://twitter.com/IgECPD&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info.&lt;br /&gt;
&lt;br /&gt;
Comments from Twitter:&lt;br /&gt;
&lt;br /&gt;
David Fischer, MD @IgECPD: RT @DrAnneEllis: RT @Aller_MD: Allergy Notes: Asthma - Twitter summary from 2013 #AAAAI meeting bit.ly/16W9hdc Tweets by me&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/FTsUr5A1wTk" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/28316957510091361/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/04/asthma-twitter-summary-from-2013-aaaai.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/28316957510091361?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/28316957510091361?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/FTsUr5A1wTk/asthma-twitter-summary-from-2013-aaaai.html" title="Asthma - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/04/asthma-twitter-summary-from-2013-aaaai.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DUEER344eyp7ImA9WhBXGU0.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-1925150825988780286</id><published>2013-04-02T09:00:00.000-04:00</published><updated>2013-04-02T09:00:06.033-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-04-02T09:00:06.033-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="local allergic rhinitis (LAR)" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Local allergic rhinitis (LAR) - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
Dr Gevaert presented on understanding the concept of local IgE production. &lt;br /&gt;
&lt;br /&gt;
Many of us have seen patients like this: typical seasonal allergic rhinitis symptoms but negative skin tests. In many European countries, the standard practice is to follow up such a patient with series of nasal allergen challenges; they are often positive. LAR is much harder to diagnose accurately in N. America where nasal allergen provocation test (NAPT) is not part of the routine practice.&lt;br /&gt;
&lt;br /&gt;
IgE is the least abundant class of immunoglobulin in human serum, it is much more tissue based and bound to cell surfaces. Many authors have published studies demonstrating local production of IgE in nasal tissue in both AR and presumed non-allergic rhinitis.&lt;br /&gt;
&lt;br /&gt;
Local allergic rhinitis is considered a subset of AR - systemic skin and blood tests are negative but there is a positive nasal allergen provocation test.&lt;br /&gt;
&lt;br /&gt;
There are challenges to the diagnosis of local IgE production. Options include NAPT, nasal biopsies, measuring IgE in nasal secretions via sponge or filter disc absorption studies.&lt;br /&gt;
&lt;br /&gt;
Local AR does improve following Allergen-specific SCIT treatment. &lt;br /&gt;
&lt;br /&gt;
This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/DrAnneEllis"&gt;https://twitter.com/DrAnneEllis&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
Diagnostic approach in patients with LAR, source: J Allergy Clin Immunol. 2012 Jun;129(6):1460-7:&lt;br /&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen="true" frameborder="0" height="389" mozallowfullscreen="true" src="https://docs.google.com/presentation/d/1fq0RuAQpaSf3TIF8I3tGg7hzpyzEdXxA2hbG-EGsz1U/embed?start=false&amp;amp;loop=false&amp;amp;delayms=3000" webkitallowfullscreen="true" width="480"&gt;&lt;/iframe&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/aldJ2_t9-iE" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/1925150825988780286/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/04/local-allergic-rhinitis-lar-twitter.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1925150825988780286?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/1925150825988780286?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/aldJ2_t9-iE/local-allergic-rhinitis-lar-twitter.html" title="Local allergic rhinitis (LAR) - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/04/local-allergic-rhinitis-lar-twitter.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DEcNRn47fSp7ImA9WhBXEUg.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-512934025284944727</id><published>2013-03-24T00:41:00.001-04:00</published><updated>2013-03-24T16:14:57.005-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-24T16:14:57.005-04:00</app:edited><title>How Global Warming Is Making Allergies Worse - NationalJewish video</title><content type="html">From &lt;a href="http://www.youtube.com/watch?v=IWRRppZEa3I"&gt;NationalJewish&lt;/a&gt;:&lt;br /&gt;
&lt;br /&gt;
If you are one of the 40 million Americans who suffer from seasonal allergies, brace yourself — this could be a rough year. Doctors say they are already seeing a surge of springtime allergies — and global warming could make things worse for a long time to come.&lt;br /&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen="" frameborder="0" height="315" src="http://www.youtube.com/embed/IWRRppZEa3I?rel=0" width="560"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
National Jewish Health (previously National Jewish Medical and Research Center) is a research institute located in Denver, Colorado specializing in respiratory, immune and allergic research and treatment. It was founded in 1899 to treat tuberculosis, and is today considered one of the world's best medical research and treatment centers (source: &lt;a href="http://en.wikipedia.org/wiki/National_Jewish_Health" rel="nofollow" target="_blank"&gt;Wikipedia&lt;/a&gt;).&lt;br /&gt;
&lt;br /&gt;
Related:&lt;br /&gt;
&lt;br /&gt;
Allergy Forecasts for 2013 - YouTube &lt;a href="http://bit.ly/11y3Nb3"&gt;http://bit.ly/11y3Nb3&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/aQeGh42ysgc" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/512934025284944727/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/how-global-warming-is-making-allergies.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/512934025284944727?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/512934025284944727?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/aQeGh42ysgc/how-global-warming-is-making-allergies.html" title="How Global Warming Is Making Allergies Worse - NationalJewish video" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://img.youtube.com/vi/IWRRppZEa3I/default.jpg" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/how-global-warming-is-making-allergies.html</feedburner:origLink></entry><entry gd:etag="W/&quot;Ck8EQX05cCp7ImA9WhBQGEo.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8265592351494036564</id><published>2013-03-21T09:00:00.000-04:00</published><updated>2013-03-21T09:00:00.328-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-21T09:00:00.328-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="SCIT" /><category scheme="http://www.blogger.com/atom/ns#" term="SLIT" /><category scheme="http://www.blogger.com/atom/ns#" term="Immunotherapy" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Immunotherapy: SCIT (“allergy shots”) and SLIT - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
There have been 83 fatalities reported from SCIT over 39 years. One confirmed fatality from SCIT from 2008-2012 period.&lt;br /&gt;
&lt;br /&gt;
Uncontrolled asthma, dosing error and pollen season are risk factors for fatal reactions from SCIT. Reducing SCIT doses during pollen season associated with significantly less severe reactions.&lt;br /&gt;
&lt;br /&gt;
NO FATALITIES reported from SLIT. Oral, throat and ear pruritus are most common AEs from SLIT. These AEs started in the first week of SLIT, but resolved within 1 week in many.&lt;br /&gt;
There is potentially increased risk of reaction to SLIT in those with previous reaction to SCIT.&lt;br /&gt;
&lt;br /&gt;
AIT (allergen immunotherapy) can be called a "profound treatment failure" because of low adherence. Less than 20% of patients who initiated AIT completed a 3 yr course.&lt;br /&gt;&lt;br /&gt;
In children, there are mean savings of $401 after starting SCIT. In children, vs. non-SCIT treated, SCIT treated patients had a median decrease in health care costs over $1500.&lt;br /&gt;
&lt;br /&gt;
Same decrease was seen in adults. Mean savings of $4000 in kids and $4400 in adults. The data are in press in JACI.&lt;br /&gt;
&lt;br /&gt;
Allergen Immunotherapy saves healthcare dollars: http://www.jacionline.org/article/S0091-6749(12)02641-3/abstract&lt;br /&gt;
&lt;br /&gt;
Unfortunately, SCIT was received by few who needed it and had high rates of discontinuation with wide variations by demographics.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;SLIT is less effective than SCIT&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
SLIT poster showed 43% reduction of symptoms vs. placebo for short ragweed SLIT after only 8-10 weeks of treatment (Creticos et al.). Ragweed SLIT tablet showed 27% symptom reduction with higher dosage. &lt;br /&gt;
&lt;br /&gt;
Grass SLIT tablet studies have shown 20% symptom improvement in adults and 26% in kids. 5 grass SLIT tablet led to 28% in symptoms. &lt;br /&gt;
&lt;br /&gt;
Overall, it looks like a 20-30% decrease in symptoms occurs rather quickly with SLIT.&lt;br /&gt;
&lt;br /&gt;
SCIT is better than SLIT In decreasing symptoms BUT adherence of SLIT may be higher. If the patient isn't using the treatment, does it matter if it’s effective?&lt;br /&gt;
&lt;br /&gt;
There are 7 cross-reactive allergen families; tropomyosin, serum albumin, non-specific lipid transfer protrein, PR10, profilin, thaumatin-like protein, carbohydrate cross-reactive determinant. &lt;br /&gt;
&lt;br /&gt;
If you were mixing an IT extract to cover all grasses in US you would mix the following: Johnson, Bermuda, Timothy.&lt;br /&gt;
&lt;br /&gt;
Timothy grass SLIT will be approved next year and will cover all northern grasses.&lt;br /&gt;
&lt;br /&gt;
Protease content of mold and cockroach extracts are 100 times higher than pollens and dust mites. Don't mix pollen, animal, dust mites with fungi and cockroach. Mixing American cockroach and mold even in 50% glycerin may result in subtherapeutic levels of fungi in the vial.&lt;br /&gt;
&lt;br /&gt;
Media-Fill Test video by JAACI: &lt;a href="http://bit.ly/YykPQG"&gt;http://bit.ly/YykPQG&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
Intra lymphatic allergen injection is less painful than venous blood draw. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/ananth720"&gt;https://twitter.com/ananth720&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/DrYesimDem"&gt;https://twitter.com/DrYesimDem&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/AsthmaBuddy"&gt;https://twitter.com/AsthmaBuddy&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/vNpJNBm8kU0" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8265592351494036564/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/immunotherapy-scit-allergy-shots-and.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8265592351494036564?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8265592351494036564?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/vNpJNBm8kU0/immunotherapy-scit-allergy-shots-and.html" title="Immunotherapy: SCIT (“allergy shots”) and SLIT - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/immunotherapy-scit-allergy-shots-and.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DU8DR3o5fyp7ImA9WhBQF0U.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-2222920690104747378</id><published>2013-03-20T09:57:00.002-04:00</published><updated>2013-03-20T09:57:56.427-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-20T09:57:56.427-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Mast Cell Disorders - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
Dr Todd Wilson presented an &lt;b&gt;"Update in Mast Cell Biology and Mast Cell Disorders".&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
KIT and FcER1 are main signaling pathways on mast cells. Multiple genetic defects have been identified in the various phenotypes of mastocytosis. The more lineages involved, the worse prognosis.&lt;br /&gt;
&lt;br /&gt;
The most common symptoms of mastocytosis are skin lesions, pruritus, flushing, diarrhea, and cramps, anaphylaxis, neuropsychiatric symptoms.&lt;br /&gt;
&lt;br /&gt;
&lt;a href="http://1.bp.blogspot.com/_LY7APi0bufs/R2FpQuwLwFI/AAAAAAAAB_g/GakzEuxOxIY/s1600-h/300px-SMCpolyhydroxysmall.jpg" onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}"&gt;&lt;img alt="" border="0" id="BLOGGER_PHOTO_ID_5143507985582768210" src="http://1.bp.blogspot.com/_LY7APi0bufs/R2FpQuwLwFI/AAAAAAAAB_g/GakzEuxOxIY/s200/300px-SMCpolyhydroxysmall.jpg" style="cursor: pointer;" /&gt;&lt;/a&gt;&lt;br /&gt;
Mast cells. Image source: &lt;a href="http://en.wikipedia.org/wiki/Mast_cells"&gt;Wikipedia&lt;/a&gt;, public domain.&lt;br /&gt;
&lt;br /&gt;
WHO Classification: cutaneous mastocytosis, systemic mastocytosis (5 subtypes), mast cell sarcoma, extra cutaneous.&lt;br /&gt;
&lt;br /&gt;
Diagnosis: Look for activating mutations in KIT, must do a bone marrow biopsy. You can miss if only test blood. Mast cells are not in peripheral blood.&lt;br /&gt;
&lt;br /&gt;
A study looked at patients with systemic reactions to Hymenoptera stings - 8% wer diagnosed with a clonal mast cell disorder.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Mast cell activation syndromes (MCAS)&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
MCAS is mast cell activation syndrome. The earliest discussion was in 1980s, a consensus conference looked at it in 1991. MCAS was defined in 2007.&lt;br /&gt;
&lt;br /&gt;
MCAS diagnostic criteria include: 1. clinical symptoms, 2. increase in baseline serum tryptase by 20% + 2 NG/ml within 4 hours, 3. clinical symptoms response to antihistamines.&lt;br /&gt;
&lt;br /&gt;
Mariana Castells, MD PhD presented on mast cell activation syndromes (MCAS). &lt;br /&gt;
&lt;br /&gt;
The term MCAS covers a broad range of diseases, from acute anaphylaxis to systemic mastocytosis. &lt;br /&gt;
&lt;br /&gt;
Majority of patients with mastocytosis have a mutation in c-kit. C-kit mutation can be determined from peripheral blood. Clonal mast cells express CD25. Mastocytosis due to D816V c-kit mutation is imatinib (Gleevec) resistant. Spindle-shaped mast cells satisfy minor criteria for mast cell disease. &lt;br /&gt;
&lt;br /&gt;
Tryptase is under-utilized and poorly-understood test.&lt;br /&gt;
&lt;br /&gt;
Mastocytosis work up: look for cutaneous lesions, full physical exam, labs (tryptase, LFTs, chem, CBC), bone marrow biopsy.&lt;br /&gt;
&lt;br /&gt;
Mast cell activation syndrome can refer to patients with symptoms of mast cell mediator release, but without clonal disease. Mast cells in idiopathic MCAS appear normal, and do not aggregate. Patients with clonal mast cell disease experience recurrent episodes of hypotension, syncope or presyncope. &lt;br /&gt;
&lt;br /&gt;
Mast cell diseases can be associated with mental “fogginess”, osteoporosis, severe reactions to drugs/venom. GI, cutaneous, and neurologic symptoms are common in idiopathic MCAS. Middle-aged women seem significantly affected. Is there a hormonal component?&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Treatment&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Indolent and smoldering systemic mastocytosis doesn't affect life span. Treat symptoms only - not with cytoreductive agents&lt;br /&gt;
&lt;br /&gt;
Related:&lt;br /&gt;
&lt;br /&gt;
Mast cell disorders/consensus report - Int Arch Allergy Immunol 2012;157:215-225.&lt;br /&gt;
Resources - TMS: The Mastocytosis Society website lists medical research centers. ECNM: European Competence Network on Mastocytosis.&lt;br /&gt;
&lt;br /&gt;
Mast Cell Disorders - figures: &lt;br /&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen="true" frameborder="0" height="389" mozallowfullscreen="true" src="https://docs.google.com/presentation/embed?id=1YO_JBIVFUgVQbAehERsI_BV8FcvTJwTUfwZsL6HjYqA&amp;amp;start=false&amp;amp;loop=false&amp;amp;delayms=3000" webkitallowfullscreen="true" width="480"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/mrathkopf"&gt;https://twitter.com/mrathkopf&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/allergistmommy"&gt;https://twitter.com/allergistmommy&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/OEU7ZAWZa1w" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/2222920690104747378/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/mast-cell-disorders-twitter-summary.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2222920690104747378?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2222920690104747378?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/OEU7ZAWZa1w/mast-cell-disorders-twitter-summary.html" title="Mast Cell Disorders - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://1.bp.blogspot.com/_LY7APi0bufs/R2FpQuwLwFI/AAAAAAAAB_g/GakzEuxOxIY/s72-c/300px-SMCpolyhydroxysmall.jpg" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/mast-cell-disorders-twitter-summary.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CUMEQXg-eyp7ImA9WhBQFkw.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-4623645132670268903</id><published>2013-03-18T09:30:00.000-04:00</published><updated>2013-03-18T09:30:00.653-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-18T09:30:00.653-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Contact Dermatitis" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Contact dermatitis and patch testing for the allergist - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
With contact dermatitis, history is extremely important. Patch testing recommended in all cases of chronic hand eczema given high positive predictive value for contact allergy. Suspect venous stasis as a contributing factor for leg dermatitis when lesions worsen or fail to respond to topical steroid treatment.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Cosmetics&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr Luz Fonacier spoke first on cosmetics.&lt;br /&gt;
&lt;br /&gt;
The average adult uses 12 personal hygiene products per day. Cosmetics are now being marketed to children. Some cosmetics (esp mascaras) are contaminated with nickel.&lt;br /&gt;
&lt;br /&gt;
Most affected site of ACD (allergic contact dermatitis) from nail varnish is the neck. Most common ACD chemicals are fragrances.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Balsam of Peru&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Food related contact dermatitis from balsam of Peru (gums, mouthwash, toothpaste) can also cause hives with tomato-containing products. Here is a list of foods containing balsam of Peru http://bit.ly/XxfR5h &lt;br /&gt;
&lt;br /&gt;
Tomato ACD is associated with balsam of Peru. The balsam is often implicated in systemic contact dermatitis rather than localized.&lt;br /&gt;
&lt;br /&gt;
Common rashes - 2-minute video overview by a dermatologist for About.com:&lt;br /&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen="" frameborder="0" height="315" src="http://www.youtube.com/embed/eDSaU1K1DXM?rel=0" width="560"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Resins&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
How to avoid formaldehyde resins - wear 100% silk, polyester, acrylic, nylon, etc. (baggy clothes).&lt;br /&gt;
&lt;br /&gt;
Resin in shin guards and neoprene can cause allergic contact dermatitis (ACD) reactions.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;PPD allergy&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
PPD is found in hair dye, body painting and temporary tattooing (like henna). PPD sensitization is life long! &lt;br /&gt;
&lt;br /&gt;
Alternatives to PPD are semi-permanent dyes based from vegetable oils.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Patch testing&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
With the current T.R.U.E. test, you can still miss 27% of clinically relevant allergens. Typical chemicals missed by the current TRUE test include propolis, fragrance mix II, DMDM hydantoin, cinnamic aldehyde, iodopropynyl.&lt;br /&gt;
&lt;br /&gt;
So, if you have a negative patch test (35% of patients) - ACD is still possible, and you need to do more tests, and consider irritant contact dermatitis, and other diagnoses. Biopsy may be indicated.&lt;br /&gt;
&lt;br /&gt;
A negative patch test is reassuring, but positive patch test doesn't prove that a serious complication is due to ACD.&lt;br /&gt;
&lt;br /&gt;
TRUE testing during pregnancy? Speakers say avoid it. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Metals &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Luckily, ACD is rare with pacers and defibrillators.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Nickel ACD&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Nickel is the #1 agent in contact dermatitis. A lichenified plaque on the abdomen is a classic presentation of nickel ACD. However, nickel can also cause systemic reactions.&lt;br /&gt;
&lt;br /&gt;
Nickel sensitization may be related to dietary nickel intake.&lt;br /&gt;
&lt;br /&gt;
Nickel is most common ACD allergen in orthodontics. Nickel allergy can cause systemic plaques (remote from contact site) if continued nickel contact despite local symptoms.&lt;br /&gt;
&lt;br /&gt;
Nickel ACD is usually a permanent sensitivity.&lt;br /&gt;
&lt;br /&gt;
In gynecological implants, the most common metal is copper.&lt;br /&gt;
&lt;br /&gt;
Pre-implantation eval (patch testing) should only be done with those with previous history of ACD.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Occupational ACD&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
About 15.5% of lifetime is spent at work, so workplace exposures do cause significant dermatitis.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;MSDS sheet&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Often, manufacturers of patch tests provide standardized panels for various professions (dental, metal workers, etc). Reading a MSDS sheet is a helpful skill for allergists to have. What to look for in MSDS - reactive components, cleaning compounds, metals.&lt;br /&gt;
&lt;br /&gt;
You can use the actual materials from work, dilute if needed, test to components separately and together. An irritant control may be an issue.&lt;br /&gt;
&lt;br /&gt;
Many chemicals implicated in ACD can also cause asthma if you inhale them (eg in machine operators, metal working fluids, glues).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Joint prostheses and ACD&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr. Pacheco discussed hip, orthopedic and medical devices. Joint prostheses go back to ancient Egypt!&lt;br /&gt;
&lt;br /&gt;
No pre-implantation testing is necessary for patients without a solid history of metal sensitization.&lt;br /&gt;
&lt;br /&gt;
The need for revision in joint replacement is 7%, It is rare that allergy is a cause of revision, mostly they are related to infection, biomechanical failure, etc.&lt;br /&gt;
&lt;br /&gt;
The presentation with ACD from metal joint replacements is not typically localized rash - it is mostly with pain, chronic effusion, etc.&lt;br /&gt;
&lt;br /&gt;
The stainless steel composition is 10-24% Ni, 18% Cr, 65% Fe.&lt;br /&gt;
&lt;br /&gt;
Bone cement is mainly methyl methacrylate, but it may contain other chemicals too (it can even be antibiotic-infused). Methyl methacrylate was once used in artificial nails but it has been removed due to asthma and ACD concerns - but it is a great joint cement!&lt;br /&gt;
&lt;br /&gt;
Both bone cement and spacers are made from methyl methacrylate in replacement joints.&lt;br /&gt;
&lt;br /&gt;
John Browning discussed contact and irritant dermatitis.&lt;br /&gt;
&lt;br /&gt;
Malassezia dermatitis is found on head, neck and upper trunk. Lanolin in Aquaphor (a common cream used in AD) can cause allergic contact dermatitis (ACD).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Phytophotodermatitis&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Photodermatitis presents with hyperpigmented marks after sun exposures due to a phototoxic reaction.&lt;br /&gt;
&lt;br /&gt;
Phytophotodermatitis is an irritant contact dermatitis from squeezing citrus fruit in the sun - it causes postinflammatory hyperpigmentation. &lt;br /&gt;
&lt;br /&gt;
ACD to mangos is itchy rash around the mouth due to urushiol (in peel and sap).&lt;br /&gt;
&lt;br /&gt;
Tomato ACD is associated with balsam of Peru. The balsam is often implicated in systemic contact dermatitis rather than localized.&lt;br /&gt;
&lt;br /&gt;
Perioral dermatitis can be due to spacers for asthma, ICS or topical steroids.&lt;br /&gt;
&lt;br /&gt;
PTBP-FR dermatitis can be due to sports gear, foam (in bras), wet suits, etc.&amp;nbsp;Sensitization by para-tertiary-butylphenolformaldehyde resin (PTBP-FR), which is particularly useful as a leather glue, has been known for 30 years (&lt;a href="http://www.ncbi.nlm.nih.gov/pubmed/2533533"&gt;http://www.ncbi.nlm.nih.gov/pubmed/2533533&lt;/a&gt;).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;“Toilet seat dermatitis" &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
“Toilet seat dermatitis" - location matches where they sit on the toilet - this is an irritant reaction from cleaning solutions on toilet seat.&lt;br /&gt;
&lt;br /&gt;
Toilet seat dermatitis is usually secondary to an irritant reaction (chemical cleaners) but can be due to urushiol exposure.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/DrAnneEllis"&gt;https://twitter.com/DrAnneEllis&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/MatthewBowdish"&gt;https://twitter.com/MatthewBowdish&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/nmchase"&gt;https://twitter.com/nmchase&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/FCc8FnTZOqo" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/4623645132670268903/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/contact-dermatitis-and-patch-testing.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4623645132670268903?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4623645132670268903?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/FCc8FnTZOqo/contact-dermatitis-and-patch-testing.html" title="Contact dermatitis and patch testing for the allergist - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://img.youtube.com/vi/eDSaU1K1DXM/default.jpg" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/contact-dermatitis-and-patch-testing.html</feedburner:origLink></entry><entry gd:etag="W/&quot;D08CSXo-fCp7ImA9WhBQEko.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-4045910676576173821</id><published>2013-03-14T08:30:00.000-04:00</published><updated>2013-03-14T11:44:28.454-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-14T11:44:28.454-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><category scheme="http://www.blogger.com/atom/ns#" term="Eosinophilic esophagitis" /><title>Eosinophilic esophagitis (EoE) - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
Dr. Aceves discussed Eosinophilic esophagitis (EoE). There was a recent Practice Parameter on EoE in 2011 JACI.&lt;br /&gt;
&lt;br /&gt;
EoE is a clinopathological diagnosis requiring 15 eos/hpf to confirm diagnosis. We must distinguish EoE from PPI respondent EE (esophageal eosinophilia). &lt;br /&gt;
&lt;br /&gt;
Clinical symptoms with EoE vary by age. Younger patients present with more vomiting, eating disorder, and failure to thrive. Older patients present more with food impaction.&lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=1d_IBX8ds8dgmGee6YZ-B7VFBzMuTYf41AiNBKunvrv8&amp;amp;w=476&amp;amp;h=346" /&gt;&lt;br /&gt;
&lt;br /&gt;
Eosinophilic Esophagitis (&lt;a href="https://docs.google.com/drawings/d/1d_IBX8ds8dgmGee6YZ-B7VFBzMuTYf41AiNBKunvrv8/edit?hl=en_US"&gt;click here to enlarge the image&lt;/a&gt;).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Diet works in EoE&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Elemental formula is highly effective in treating EoE. There is a good evidence that foods play a role. The most common food triggers in EoE are milk, wheat egg, soy, grains, legumes, meats.&lt;br /&gt;
&lt;br /&gt;
Elemental diet in adult EoE patients leads to pathological improvements in as little as 2-4 weeks. Multiple studies show elemental diet helps in treatment of EoE in children. Aceves reviewed the Peterson study in 2013 AJG showing that elemental diet is also helpful in adults but there is a big difference in adherence to the diet.&lt;br /&gt;
&lt;br /&gt;
Elimination diet options includes food testing based or 6 (really 8) food elimination diet. Milk is the most significant trigger in children.&lt;br /&gt;
&lt;br /&gt;
Resolution rates of EoE on empiric elimination diet are 50-81% in various studies.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Milk is a problem in EoE&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Cows milk and wheat seem to be frequent triggers in EoE in both adults and children. In both kids and adults when foods are reintroduced the most common EoE triggers are: milk and wheat.&lt;br /&gt;
&lt;br /&gt;
Directed elimination diet (SPT and APT) plus milk elimination leads to 77% resolution.&lt;br /&gt;
&lt;br /&gt;
PPV of patch testing for food in EoE is 44%. SPT was 13% at best. 15-24% of EoE pts have a history of food anaphylaxis also. &lt;br /&gt;
&lt;br /&gt;
EoE food testing: combining prick and patch test has PPV 44%, NPV as high as 92% (except milk 44%).&lt;br /&gt;
&lt;br /&gt;
Dr Aceves is pondering more of a 4 food elimination diet (milk, egg, wheat and soy) as these appear to be the most common EoE triggers (rather than 6 food elimination diet).&lt;br /&gt;
&lt;br /&gt;
Data presented in the TIGERS conference (focused on GI diseases with eosinophilia) suggested that milk elimination did not necessarily have to rule out drinking extensively heated milk in EoE.&lt;br /&gt;
&lt;br /&gt;
A guide to successfully managing Eosinophilic Esophagitis in Q&amp;amp;A format from APFED &lt;a href="http://goo.gl/0l9PX"&gt;http://goo.gl/0l9PX&lt;/a&gt;:&lt;br /&gt;
&lt;br /&gt;
&lt;iframe allowfullscreen="allowfullscreen" frameborder="0" height="315" src="http://www.youtube.com/embed/_vB2wR7ORaE?rel=0" width="560"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/ananth720"&gt;https://twitter.com/ananth720&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/IgECPD"&gt;https://twitter.com/IgECPD&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/mrathkopf"&gt;https://twitter.com/mrathkopf&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;br /&gt;
&lt;br /&gt;
Comments from Twitter: &lt;br /&gt;
&lt;br /&gt;
@PedNutritionGuy: Excellent synopsis of Eo #esophagitis #nutrition updates from 2013 #AAAAI meeting goo.gl/YwrEo #RDchat #allergy&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/dG57pPxalkE" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/4045910676576173821/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/eosinophilic-esophagitis-eoe-twitter.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4045910676576173821?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/4045910676576173821?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/dG57pPxalkE/eosinophilic-esophagitis-eoe-twitter.html" title="Eosinophilic esophagitis (EoE) - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://img.youtube.com/vi/_vB2wR7ORaE/default.jpg" height="72" width="72" /><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/eosinophilic-esophagitis-eoe-twitter.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C0UERHk5cCp7ImA9WhBQEUU.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-3640650703390959366</id><published>2013-03-13T09:26:00.001-04:00</published><updated>2013-03-13T09:26:45.728-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-13T09:26:45.728-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Drug allergy  - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
David Khan, MD presented a case based approach to drug allergy. Dr. Castells also had a presentation on the topic.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Anaphylaxis during&amp;nbsp;anesthesia&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Anaphylaxis during&amp;nbsp;anesthesia&amp;nbsp;is complicated to diagnose due to the large number of drugs administered. Antibiotics, induction agents, latex are all potential triggers or perioperative anaphylaxis. Skin testing and history remain the mainstay of diagnosis for drug allergy in perioperative reactions. French literature has most robust data on concentrations to use in skin testing for intraoperative drugs. In 2/3 cases, skin testing can find causal agent in perioperative anaphylaxis. &lt;br /&gt;
&lt;br /&gt;
Chlorhexidine digluconate is a popular disinfectant, and may be a cause of perioperative anaphylaxis.&lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=1z2IIXEUFkCoDvTcSpBkXm_IplJ0SL1tLUbJy-ZBX1dE&amp;amp;w=476&amp;amp;h=346" /&gt;&lt;br /&gt;
&lt;br /&gt;
Classification of adverse reactions to drugs, using the "SOAP III" mnemonic (click to &lt;a href="https://docs.google.com/drawings/d/1z2IIXEUFkCoDvTcSpBkXm_IplJ0SL1tLUbJy-ZBX1dE/edit"&gt;enlarge the image&lt;/a&gt;).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Drug challenges&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Clinical indications for drug challenges: in the US, we use it to rule out drug allergy.&lt;br /&gt;
&lt;br /&gt;
Contraindications to drug challenge include severe cutaneous drug reactions (e.g. Stevens- Johnson), specific organ involvement (DRESS).&lt;br /&gt;
&lt;br /&gt;
Many patients with negative drug challenges will have transient subjective symptoms during challenge. These patients may be experiencing drug-induced vocal cord dysfunction (VCD) Consider placebo control. &lt;br /&gt;
&lt;br /&gt;
New code for ingestion challenges. 95076. At least 61 minutes, incremental graded challenge. Inclusive of E/M.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Desensitization&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
When do we desensitize? When there is a high suspicion of hypersensitivity, and a positive skin test.&lt;br /&gt;
&lt;br /&gt;
Desensitizations generally start with 1/10,000 of target dose. &lt;br /&gt;
&lt;br /&gt;
Severe reactions during beta-lactam desensitizations are rare. Same holds true for chemotherapy and monoclonal antibody desensitizations.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Aspirin desensitization&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Aspirin desensitizations have a higher reaction rate, but can still be done in the outpatient setting. Combined zileuton, montelukast is most effective in reducing upper, lower respiratory response during ASA challenge, and desensitization.&lt;br /&gt;
&lt;br /&gt;
Omalizumab may be end-line option for ASA-sensitive CRS with NP patients who fail ASA desensitization therapy. Source: JACI 2013&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;CF patients&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Decreased FEV1 or transplant status is NOT contraindications to medication desensitization in patients with CF. In CF patients with severely reduced lung function (eg, pre-transplant). extended protocol (eg, 20-step) medication desensitizations are often successful.&lt;br /&gt;
&lt;br /&gt;
Chemotherapy agents &lt;br /&gt;
&lt;br /&gt;
Most reactions to chemotherapy agents occurred after the *last* step in a 12-step protocol. Source: Castells JACI 2008.&lt;br /&gt;
&lt;br /&gt;
Dr. Castells: 1) Anaphylaxis during desensitization occurs regardless of premedication given. 2) ALWAYS send a tryptase level.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;ACEI reactions&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
ACEI cough can last for TWO MONTHS after ACEI is removed.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/allergistmommy"&gt;https://twitter.com/allergistmommy&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/nmchase"&gt;https://twitter.com/nmchase&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/54BfIs7e-bQ" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/3640650703390959366/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/drug-allergy-twitter-summary-from-2013.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3640650703390959366?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/3640650703390959366?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/54BfIs7e-bQ/drug-allergy-twitter-summary-from-2013.html" title="Drug allergy  - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/drug-allergy-twitter-summary-from-2013.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DU4BQn04cCp7ImA9WhBQEUU.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-8606740348863107035</id><published>2013-03-12T09:00:00.000-04:00</published><updated>2013-03-13T11:19:13.338-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-13T11:19:13.338-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Cockroach" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><category scheme="http://www.blogger.com/atom/ns#" term="Mouse allergy" /><category scheme="http://www.blogger.com/atom/ns#" term="Pets" /><title>Pet and pest allergy - practice parameters - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Pet allergies&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Did you know? Cat allergens can be found even in homes without pets, work and classrooms. Pet allergens can be passively transferred on clothing. &lt;br /&gt;
&lt;br /&gt;
Editor’s note: Cat allergen can be found anywhere, but the question is: does it cause symptoms anywhere?&lt;br /&gt;
&lt;br /&gt;
Cat allergen in home declines slowly after pet removal. However, extensive cleaning and removal of carpeting can help. It takes up to 3-4 months for the cat allergen level to go to baseline.&lt;br /&gt;
&lt;br /&gt;
Is there such a thing as a hypoallergenic pet? Quick answer: No. Allergens are present in all pets, regardless of pedigree and breeding. If you wash your pet to reduce allergen, get used to doing it at least weekly.&lt;br /&gt;
&lt;br /&gt;
There might be an inverse association between cat allergen exposure and sensitization. However, genetics play a role here as well. For example, if mom has asthma, kids' exposure to cat in early life (before age of 5 yrs) increases risk of wheezing/asthma. On the other hand, some studies demonstrate protective effect of cat on asthma development. In very atopic children, risk of exposure likely outweighs benefit. &lt;br /&gt;
&lt;br /&gt;
Interestingly, children with early life dog exposure appear to have fewer infections of respiratory tract and middle ear.&lt;br /&gt;
&lt;br /&gt;
Already sensitized? Don't get a pet, lest you increase the risk of asthma. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Measures to reduce exposure to allergen&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Pet removal remains the first line strategy. Keep pets out of bedroom - very important!&lt;br /&gt;
&lt;br /&gt;
Allergen encasings for bedding should have pore size smaller than 6 microns, and they should be washable. HEPA filters should have a filtration efficiency of 99.97%. Duct cleaning has not been specifically proven to reduce pet allergen exposure. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Practice parameter on rodents&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Elizabeth Matsui presented on the Practice parameter on rodents.&lt;br /&gt;
&lt;br /&gt;
Mice can squeeze through holes only 1/4 inch in diameter. Rodents prefer seeds and grains as food source. The major mouse allergen (Mus m 1) is 4 times higher in male mice, primarily found in urine. &lt;br /&gt;
&lt;br /&gt;
Prevalence of mouse allergen ranges from 75-100% in US homes. However, concentration of allergen is highest in big cities. Mouse allergen can be detected in the air. The median levels in some homes approach levels seen in mouse laboratories. There is 20% rate of occupational sensitization to mouse.&lt;br /&gt;
Rat allergen is less important in allergic disease, because they reside primarily outdoors.&lt;br /&gt;
&lt;br /&gt;
Mouse sensitization is a risk factor for allergic disease (wheeze, eczema, rhinitis). Mouse allergen exposure is associated with asthma morbidity.&lt;br /&gt;
&lt;br /&gt;
SPT for mouse epithelia has 47% sensitivity and 83% specificity. &lt;br /&gt;
&lt;br /&gt;
The best way to decrease exposure to mouse allergen is Integrated pest management: assess and modify facilitative factors, use traps and rodenticide. Integrated pest management does reduce allergen levels.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Cockroach allergy&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Ginger Chew presented on cockroach allergy. 10% of US population is sensitized to cockroach. &lt;br /&gt;
&lt;br /&gt;
High-level sensitization to cockroach is associated with increased healthcare utilization. Cockroach exposure is associated with illness, even in the absence of allergic sensitization. Remember, exposure to cockroach can also occur in the school setting! &lt;br /&gt;
&lt;br /&gt;
Integrated pest management helps reduce exposure to cockroach, but must be continued to be effective. Most integrated pest management strategies do judiciously use pesticides. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/allergistmommy"&gt;https://twitter.com/allergistmommy&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;br /&gt;
&lt;br /&gt;
Comments from Twitter: &lt;br /&gt;
&lt;br /&gt;
Dr John Weiner @AllergyNet: Another superb summary by @Allergy&lt;br /&gt;
&lt;br /&gt;
@Allergy: Thank you, John, there will be a few more summaries over the next week - all are labeled #AAAAI here: bit.ly/12PtNQg&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/f9e0kTH7ncw" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/8606740348863107035/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/pet-and-pest-allergy-practice.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8606740348863107035?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/8606740348863107035?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/f9e0kTH7ncw/pet-and-pest-allergy-practice.html" title="Pet and pest allergy - practice parameters - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/pet-and-pest-allergy-practice.html</feedburner:origLink></entry><entry gd:etag="W/&quot;C0MBQH8-fSp7ImA9WhBQF0s.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-5678643456299129147</id><published>2013-03-08T08:00:00.000-05:00</published><updated>2013-03-20T02:37:31.155-04:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-20T02:37:31.155-04:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Atopic Dermatitis" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Filaggrin mutations and atopic dermatitis - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
Alan Irvine MD presented on the &lt;b&gt;Role of filaggrin mutations in human disease and allergic sensitization&lt;/b&gt;.&lt;br /&gt;
&lt;br /&gt;
Filaggrin is a filament aggregating protein. Stratum corneum is compromised in patients with filaggrin mutation. Staphylococcus aureus colonization can be increased in patients with filaggrin mutation, due to dysregulation of skin pH. &lt;br /&gt;
&lt;br /&gt;
Filaggrin mutations are highly associated with eczema and ichthyosis vulgaris. Early onset asthma in patients with atopic dermatitis is also highly associated with filaggrin mutation. Other associations with filaggrin mutation include peanut sensitization.&lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=1OgBFJKwtRbeKjXTV-Tt4xUQATpCq7hXSrgNIy_s_ntw&amp;amp;w=480&amp;amp;h=360" /&gt;&lt;br /&gt;
&lt;br /&gt;
Allergic (atopic) march (click &lt;a href="https://docs.google.com/drawings/d/1OgBFJKwtRbeKjXTV-Tt4xUQATpCq7hXSrgNIy_s_ntw/edit?hl=en_US"&gt;here to enlarge the image&lt;/a&gt;).&lt;br /&gt;
&lt;br /&gt;
10% of population has a filaggrin mutation (1:10 European carries 1 null filaggrin mutation). One null allele is associated with milder atopic dermatitis than having no filaggrin at all.&lt;br /&gt;
&lt;br /&gt;
Cat exposure in patients with filaggrin mutation is nearly always associated with atopic dermatitis.&lt;br /&gt;
&lt;br /&gt;
The bottom line is that a filaggrin mutation in patients with eczema markedly increases risk of developing atopic sensitization and asthma. Overall risk is asthma increased by 50% with filaggrin mutation and AD. 40% of people carrying Filaggrin null allele develop asthma.&lt;br /&gt;
&lt;br /&gt;
Peanut allergy risk is 5.4 times higher with filaggrin mutation. &lt;br /&gt;
&lt;br /&gt;
Vicious cycle: FLG mutation --&amp;gt; defective skin barrier --&amp;gt; allergen entry/sensitization --&amp;gt; Th2 inflammation --&amp;gt; inhibits FLG expression. &lt;br /&gt;
&lt;br /&gt;
AD cycle: 1. Mutational defect, 2. Defective barrier, 3. Entry of allergens, 4. Th2 based inflammation, then go back to 1.&lt;br /&gt;
&lt;br /&gt;
For known FLG deficient patient siblings, avoid cat exposure and soaps. &lt;br /&gt;
&lt;br /&gt;
Keep in mind that filaggrin is not the only genetic problem that leads to atopic dermatitis and atopy.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Atopic dermatitis&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr. Donald Leung presented on atopic dermatitis and the skin barrier.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Scratching&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
If children with atopic dermatitis are allowed to scratch they will develop chronic papules with lichenification that are hard to heal. Damaged skin barrier from excoriation then becomes a nidus for infection and allergen absorption.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;TSLP&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Tape stripping of the skin is a model of scratching - it causes a sharp rise in TSLP levels within an hour of the stripping. TSLP is the "master switch" to polarize towards Th2 responses - hence it is an exciting target to block in novel therapeutics for AD.&lt;br /&gt;
&lt;br /&gt;
Th22 cells infiltrate acute AD lesions, produce IL-22 and promote skin damage; they are also important in the chronic phase.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Filaggrin&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Reminder that AD skin is filaggrin-deficient, leading to increased permeability; it increases risk of food allergy and eczema herpeticum. Filaggrin mutations/deficiency also associated with respiratory allergy as well. Filaggrin deficiency also predisposes to damage mediated by Staph aureus alpha toxin. Phenotypes of AD are very different if Filaggrin deficient vs. not filaggrin deficient; better prognosis if filaggrin levels normal.&lt;br /&gt;
&lt;br /&gt;
Lisa Beck has published a detailed review of atopic dermatitis in the Feb 2013 volume of J Allergy Clin Immunol. &lt;br /&gt;
&lt;br /&gt;
Laminin is a basement membrane protein - there are recently identified mutations in its gene in some patients.&lt;br /&gt;
&lt;br /&gt;
Figures:&lt;br /&gt;
&lt;br /&gt;
&lt;iframe src="https://docs.google.com/presentation/d/1uxi6mvvzDXjAsjXYepEJKESblMJQJ5iBLpQ4pXFZZKU/embed?start=false&amp;loop=false&amp;delayms=3000" frameborder="0" width="480" height="389" allowfullscreen="true" mozallowfullscreen="true" webkitallowfullscreen="true"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/allergistmommy"&gt;https://twitter.com/allergistmommy&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/ananth720"&gt;https://twitter.com/ananth720&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/DrAnneEllis"&gt;https://twitter.com/DrAnneEllis&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/IgECPD"&gt;https://twitter.com/IgECPD&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/DrYesimDem"&gt;https://twitter.com/DrYesimDem&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/MatthewBowdish"&gt;https://twitter.com/MatthewBowdish&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/3RCLQti0CR4" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/5678643456299129147/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/filaggrin-mutations-and-atopic.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5678643456299129147?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5678643456299129147?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/3RCLQti0CR4/filaggrin-mutations-and-atopic.html" title="Filaggrin mutations and atopic dermatitis - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/filaggrin-mutations-and-atopic.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CUcEQX07eCp7ImA9WhBRFks.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-2902580652027705756</id><published>2013-03-07T08:30:00.000-05:00</published><updated>2013-03-07T08:30:00.300-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-07T08:30:00.300-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="Immunodeficiency" /><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="PIDD" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Primary immunodeficiencies - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
Dr. Lisa Filipovich presented on "&lt;b&gt;New insights and opportunities in curative therapies for primary immunodeficiency&lt;/b&gt;".&lt;br /&gt;
&lt;br /&gt;
From @IgECPD: “For the uninitiated Immunology is a series of colourful circles on a white background labeled with capital letters/numbers, linked by arrows”.&lt;br /&gt;
&lt;br /&gt;
The first successful allogenic bone marrow transplant for SCID was almost 44 years ago. Over 150 primary immunodeficiencies (PIDs) currently recognized. More than 120 genes are linked to PIDs; many PIDs are prematurely lethal and deserve curative treatment such as BMT or gene therapy.&lt;br /&gt;
&lt;br /&gt;
Dr Bonilla: according to 2011 WHO/IUIS classification there are 181 PIDs, with many unknown genetic defects. There are probably about 1250 PIDs according to Dr Bonilla's calculation. Dr. Bonilla: Theoretical estimate of total number of primary immunodeficiency disorders (PIDs) around 1250&lt;br /&gt;
&lt;br /&gt;
It is important to diagnosis SCID early to provide protective isolation, avoid live vaccines, and allow time to optimally plan the BMT.&lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=1gTJIwcPMiZXQ1yt1-uDWhPMKWDl5T02bc-qpJW8jeN4&amp;amp;w=480&amp;amp;h=360" /&gt;&lt;br /&gt;
Primary immunodeficiency disorders (PIDD) (&lt;a href="https://docs.google.com/drawings/d/1gTJIwcPMiZXQ1yt1-uDWhPMKWDl5T02bc-qpJW8jeN4/edit?hl=en_US"&gt;click to enlarge the image&lt;/a&gt;).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Diagnosis of PIDs&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;TRECs for diagnosis &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Population based &lt;b&gt;Newborn screening program (NBS)&lt;/b&gt; for SCID via TRECs has been very successful. Newborn screening for SCID is now available in 50% of US states. Head of HHS has been pushing for more.&lt;br /&gt;
&lt;br /&gt;
A prospective SCID study is underway. 50% were discovered because of newborn screening or family history. Diagnosis at 15 days vs 181 days.&lt;br /&gt;
&lt;br /&gt;
Adding &lt;b&gt;KRECs&lt;/b&gt; to NBS for SCID (TRECs) will help detect B cell defects as well as determining SCID subtypes. Explanation of abbreviations:&amp;nbsp;kappa-deleting recombination excision circles (KRECs) and T-cell receptor excision circles (TRECs).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Whole Exome Sequencing (WES)&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Whole Exome Sequencing (WES) is used in diagnosing PIDs. Cost of WES ranges between $1,300 an $1,700. WES sequences only known exomes, and it cannot sequence certain genes (highly polymorphic genes such as MHC).&lt;br /&gt;
&lt;br /&gt;
Whole exome sequencing can be useful for diagnosis of patients with undiagnosed PIDs. Costs decreasing rapidly over time. Whole exome sequencing requires time-intensive post-sequencing analysis - this is the main barrier to quick turnaround.&lt;br /&gt;
&lt;br /&gt;
Dr Jack Routes: New screening for 22q11.2 microdeletion (DiGeorge) syndrome employs qRT-PCR for copy number variations in TBX1 gene. &lt;br /&gt;
&lt;br /&gt;
Newborn screening for SCID will benefit from new advances in WES/iPS technology, especially for rare/novel disorders. &lt;br /&gt;
&lt;br /&gt;
A sad case: A 22q patient developed VZV pneumonia after routine 12-month vaccines. CD3 count was 400 when checked later. Remember to report vaccine reactions to VAERS for confirmatory testing, documentation, and patient compensation fund access.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;BMT&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
However, there is less than a 25% chance of finding a matched sibling donor for BMT - national marrow donor program critical to enhance this process. "&lt;b&gt;BMDW&lt;/b&gt;" - bone marrow donors worldwide - is a database of over 50K donors that HCP can search for matches. Not surprisingly, outcomes are superior with HLA-identical sibling donors compared to unrelated haploidentical donors.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Gene therapy&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Gene therapy for SCID and other PIDs has been challenging; now starting to look safer and more promising.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Antibody deficiency&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
The delay in diagnosis of patients with antibody deficiency is up to 20 yrs (average is 8 yrs).&lt;br /&gt;
&lt;br /&gt;
Assessment of T cell independent response should wait until the child completes routine immunizations (approximately 18 months).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Response to vaccines &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
A protective level is equal or greater than 1.3. A positive response is there if it goes from unprotected level to protected level.&lt;br /&gt;
&lt;br /&gt;
A protective response to each pneumococcal vaccine is 1.3 mcg/ml or higher. The rise for each pneumococcal serotypes varies by age and by serotype.&lt;br /&gt;
&lt;br /&gt;
Source:  JACI Sept 2012:130:S1-S24 - Working group report on use of vaccine response in dx of immune deficiency.&lt;br /&gt;
&lt;br /&gt;
There is a screening available for high risk patients (ENT, Pulmonology, A/I pts) for immunoglobulin deficiency on a dry blood spot (developed by Quest lab). It needs only 10-30 mcl blood. Dry blood spot QuIg analysis correlates with whole blood analysis.&lt;br /&gt;
&lt;br /&gt;
April 25 is Primary Immunodeficiency Day. Visit &lt;a href="http://www.clinimmsoc.org/"&gt;http://www.clinimmsoc.org&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;CVID&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr Tony Bonilla: Known gene defects in CVID account for very tiny fraction (less than 5%) of total CVID cases. GWAS in CVID yielded numerous candidate genes, but few were confirmed as of late as playing direct causal role (JACI 2011).&lt;br /&gt;
&lt;br /&gt;
CVID is a truly heterogeneous disorder. Better definitions are needed for subgroup stratification.&lt;br /&gt;
&lt;br /&gt;
Decreased switched-memory (CD27+/IgD-/IgM-) B-cells are found in numerous PIDs; NOT exclusive to, or diagnostic of CVID. Diagnosis of CVID can NOT be made by B-cell phenotyping alone.&lt;br /&gt;
&lt;br /&gt;
Dr Warnatz: Naive t-cell measurements should be a routine component of screening in patients with CVID; defects are commonly seen.&lt;br /&gt;
&lt;br /&gt;
Patients with CVID have increased CD20-mediated BCR internalization, and subsequent hyporesponsiveness.&lt;br /&gt;
&lt;br /&gt;
Related:&lt;br /&gt;
&lt;br /&gt;
Primary immunodeficiencies in patients with recurrent ENT infections. JACI 2013.&lt;br /&gt;
&lt;a href="http://www.jacionline.org/article/S0091-6749(12)02909-0/fulltext"&gt;http://www.jacionline.org/article/S0091-6749(12)02909-0/fulltext&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/DrAnneEllis"&gt;https://twitter.com/DrAnneEllis&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/DrYesimDem"&gt;https://twitter.com/DrYesimDem&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/IgECPD"&gt;https://twitter.com/IgECPD&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/nmchase"&gt;https://twitter.com/nmchase&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/mrathkopf"&gt;https://twitter.com/mrathkopf&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/v0IaNPSAoTQ" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/2902580652027705756/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/primary-immunodeficiencies-twitter.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2902580652027705756?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/2902580652027705756?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/v0IaNPSAoTQ/primary-immunodeficiencies-twitter.html" title="Primary immunodeficiencies - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/primary-immunodeficiencies-twitter.html</feedburner:origLink></entry><entry gd:etag="W/&quot;CEYERn8zfSp7ImA9WhBRF0s.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-6568714611154313894</id><published>2013-03-06T09:30:00.000-05:00</published><updated>2013-03-08T12:01:47.185-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-08T12:01:47.185-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><category scheme="http://www.blogger.com/atom/ns#" term="Cough" /><title>Chronic cough  - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
From &lt;a href="https://twitter.com/MatthewBowdish"&gt;https://twitter.com/MatthewBowdish&lt;/a&gt;:&lt;br /&gt;
&lt;br /&gt;
Cough is a $1B, with a "B," industry per year.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;What causes cough?&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr Canning: What causes cough? Mechanical stimulation (mucus, foreign body, tumor), capsaicin, bradykinin, citric/tartaric acid.&lt;br /&gt;
&lt;br /&gt;
There are &lt;b&gt;three big causes of chronic cough&lt;/b&gt;: rhinitis, asthma, GERD - but also chronic bronchitis, foreign body, ACEI, infection, ILD, tumor.&lt;br /&gt;
&lt;br /&gt;
In multiple species, there are only two main/conserved/distinct pathways for cough: C-fibers and cough receptors. Cough receptors are essentially mechanoreceptors, they're insensitive to capsaicin but sensitive to acid.&lt;br /&gt;
&lt;br /&gt;
Icatibant is approved for HAE. It's not a viable tx for cough, but bradykinin antagonism is a viable target for cough.&lt;br /&gt;
&lt;br /&gt;
Dr. Brooks: Cough is a warning sign similar to pain and if we understood pain reflexes better, we might understand cough better. Cough reflex probably appeared more than 100 million years ago.&lt;br /&gt;
&lt;br /&gt;
Dr. Balkissoon: Response to reflux cough can be quite lengthy and high doses (PPI BID and ranitidine qhs + lifestyle measures). Metoclopramide (Reglan) can be used for aggressive medication therapy with chronic cough due to GERD (it tightens lower esophageal sphincter). Reglan is also helpful as prokinetic agent in addition to effects on LES.&lt;br /&gt;
&lt;br /&gt;
Postinfectious (post viral) cough is extremely stubborn. It can last for months.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;ACEI and cough&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
ACEI cough mechanism probably related to substance P, bradykinin, PGs. Patients on ACEI for CHF have worse cough than those on ACEI for HTN.&lt;br /&gt;
&lt;br /&gt;
ACEI cough can last for TWO MONTHS after ACEI removed. &lt;br /&gt;
&lt;br /&gt;
&lt;img src="https://docs.google.com/drawings/pub?id=1HvWZout62rOaRa0Vi3BJDab3JjZTk2BZtMub04nY69g&amp;amp;w=476&amp;amp;h=346" /&gt;&lt;br /&gt;
&lt;br /&gt;
Differential diagnosis of cough, a simple mnemonic is GREAT BAD CAT TOM. Click &lt;a href="https://docs.google.com/drawings/d/1HvWZout62rOaRa0Vi3BJDab3JjZTk2BZtMub04nY69g/edit"&gt;here to enlarge the image&lt;/a&gt;:&amp;nbsp;(GERD (reflux), Laryngopharyngeal Reflux (LPR), Rhinitis (both allergic and non-allergic) with post-nasal drip (upper airway cough syndrome, UACS), Embolism, e.g. PE in adults, Asthma, TB (tuberculosis), Bronchitis, pneumonia, pertussis, protracted/persistent bacterial bronchitis (PBB), Aspiration, e.g foreign body in children, Drugs, e.g. ACE inhibitor, CF in children, Cardiogenic, e.g. mitral stenosis in adults, Achalasia in adults, Thyroid enlargement, e.g. goiter, "Thoughts" (psychogenic), Other causes, Malignancy, e.g. lung cancer in adults).&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Treatment of chronic cough&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Cough suppressing meds can be centrally-acting (opioids, dextromethorphan, diphenhydramine) or peripheral (benzonatate). &lt;br /&gt;
&lt;br /&gt;
Laryngeal sensory neuropathy (neurogenic cough) can be treated with gabapentin, pregabalin, amitriptyline, nortriptyline.&lt;br /&gt;
&lt;br /&gt;
BREAK THE COUGH CYCLE! Diet, PPI, nasal steroids, benzonatate, oral steroids, exercises.&lt;br /&gt;
&lt;br /&gt;
A suggested cough algorithm: chlorpheniramine 8 mg bid-qid, if no help then prednisone 40mg x 5 days then 20 mg x 5 days, if help ICS plus maybe LTRA. Then, aggressive GERD therapy, if no help, start Reglan 10 mg bid-qid, then other diagnostic studies.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;How to set up a cough center in private practice&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Dr. Madell Sher: A cough center is a nice way to expand your scope of practice and make a difference in your community. We have a global approach to disease and cough should be right up our alley as allergists/asthma specialists.&lt;br /&gt;
&lt;br /&gt;
Set up separate phone number, branded center and acquire a website.&lt;br /&gt;
&lt;br /&gt;
@MatthewBowdish: Dr Sher just mentioned our cough center at the Storms Clinic! http://bit.ly/ZxTtim  &lt;br /&gt;
&lt;br /&gt;
Review previous records, and include a 2-page questionnaire including Leicester cough questionnaire, physical exam with laryngeal hyperfxn on expiratory phase. VCD is often inspiratory hypofunction, but just as important to us is laryngeal hyperfxn on expiratory phase.&lt;br /&gt;
&lt;br /&gt;
Leicester questionnaire evaluates social isolation, depression, anxiety and others, expressing concern.&lt;br /&gt;
&lt;br /&gt;
Dr Sher’s experience with 275 pts - CRS 70%, UACS 55%, GERD 53%, Asthma 13%, Eos Bronchitis 3%, some ACEI/lung ca/bronchiectasis.&lt;br /&gt;
&lt;br /&gt;
Response to PPIs in chronic cough can take months.&lt;br /&gt;
&lt;br /&gt;
Dr. Sher: In the non-smoker without ACEI and a normal CXR and you've treated rhinitis/GERD/asthma, then IT'S THE COUGH REFLEX, STUPID!&lt;br /&gt;
&lt;br /&gt;
Cough reflex sensitivity has variable inflammatory, neurogenic and behavioral components. All “coughers” are different and have variable expression.&lt;br /&gt;
&lt;br /&gt;
Upper Airway Cough Syndrome (post-nasal drip) is probably the most common etiology.&lt;br /&gt;
&lt;br /&gt;
Chlorpheniramine is the best antihistamines for chronic cough - non-sedating antihistamines do not work as well, if at all. &lt;br /&gt;
&lt;br /&gt;
Diet may be more important than PPI in chronic cough. &lt;br /&gt;
&lt;br /&gt;
Dr. Sher: Asthma is an uncommon cause and inhalers (especially powders such as Advair Diskus) can be irritating.&lt;br /&gt;
&lt;br /&gt;
Oral steroids are very important in chronic cough, especially postinfectious cough; variable effect in acute viral cough. Longer, low-dose oral steroid therapy may be needed (similar to neurodermatitis).&lt;br /&gt;
&lt;br /&gt;
Dr. Balkissoon discussed his experience in an academic cough center. A nice part about being at National Jewish is to have all specialists under the same roof (pulm, AI, ENT, GI, speech path). Speech therapy is extremely helpful in chronic cough, from respiratory retraining to vocal exercises.&lt;br /&gt;
&lt;br /&gt;
Gary Stadmauer spoke on importance of rhinolaryngoscopy in chronic cough. Rhinolaryngoscopy is an extension of the physical exam via a small device. You you cannot be a true upper respiratory specialist without looking at all of the upper airway . &lt;br /&gt;
&lt;br /&gt;
Reflux-cough patients do not necessarily improve on rhinolaryngoscope even though they may improve clinically after treatment with medications.&lt;br /&gt;
&lt;br /&gt;
@MatthewBowdish: Everyone tweeting allows me to 'attend' multiple sessions. Don't forget to download the #AAAAI meeting app - it's great to plan your day - most evaluations can be done via the app too.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/MatthewBowdish"&gt;https://twitter.com/MatthewBowdish&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;br /&gt;
&lt;br /&gt;
Comments from Twitter:&lt;br /&gt;
&lt;br /&gt;
Farris Timimi, MD @FarrisTimimi: Gr8t overview!&lt;br /&gt;
&lt;br /&gt;
Ann Wu MD MPH @Asthma3Ways: Good summary. Cough more than 8 wks in adults: chronic.&lt;br /&gt;
&lt;br /&gt;
@CAREAllergy: I am glad Cough got the attention it deserves and our work did not go in vain. Thanks to all of our great speakers and attendees!&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/GjsQd1hgnIk" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/6568714611154313894/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/chronic-cough-twitter-summary-from-2013.html#comment-form" title="0 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6568714611154313894?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/6568714611154313894?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/GjsQd1hgnIk/chronic-cough-twitter-summary-from-2013.html" title="Chronic cough  - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>0</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/chronic-cough-twitter-summary-from-2013.html</feedburner:origLink></entry><entry gd:etag="W/&quot;DUUBRX8zeCp7ImA9WhBREk8.&quot;"><id>tag:blogger.com,1999:blog-2057269305378114997.post-5370625647267075630</id><published>2013-03-01T10:24:00.003-05:00</published><updated>2013-03-02T07:27:34.180-05:00</updated><app:edited xmlns:app="http://www.w3.org/2007/app">2013-03-02T07:27:34.180-05:00</app:edited><category scheme="http://www.blogger.com/atom/ns#" term="AAAAI" /><category scheme="http://www.blogger.com/atom/ns#" term="Twitter" /><title>Early life environment and microbiome influence on allergic diseases - Twitter summary from 2013 #AAAAI meeting</title><content type="html">&lt;a href="http://photos1.blogger.com/blogger/2608/483/1600/chat_icon_01.png"&gt;&lt;img alt="" border="0" src="http://photos1.blogger.com/blogger/2608/483/200/chat_icon_01.png" style="cursor: pointer; float: right; margin: 0pt 0pt 10px 10px;" /&gt;&lt;/a&gt;This summary was compiled from the tweets posted by allergists/immunologists who attended the 2013 annual meeting of the American Academy of Allergy Asthma and Immunology (AAAAI) (see the list at the end). The tweets were labeled #AAAAI. The text was edited and modified by me.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Early life environmental influences on development in allergic diseases&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Susan Prescott MD PhD (@susanprescott88) presented on early life environmental influences on development in allergic diseases&lt;br /&gt;
&lt;br /&gt;
Allergic disease is the most common, and the earliest onset, non-communicable disease. Non-communicable diseases (NCD) are more common in affluent and industrialized nations, but ironically burden the poor the most. Despite the prevalence of allergic disease, it has largely been neglected on the world political stage, when compared to other NCD's.&lt;br /&gt;
&lt;br /&gt;
By 2030, expect 52 million deaths from NCD's. This crisis can't be addressed without combatting factors which dictate our risk. Big 4 NCDs - Type 2 DM, COPD, heart disease and cancer. Inflammation is a common feature of all NCDs (non communicable disease). &lt;br /&gt;
&lt;br /&gt;
Dr Prescott: We live a life similar to animals in captivity, so we shouldn't be surprised when we have stress levels similar to them. &lt;br /&gt;
&lt;br /&gt;
Jonathan Tam ‏@sirartichoke: Irony: Dr. Prescott warns of the dangers of sedentary indoor lives to dark room full of sitting allergists with full day of lectures planned.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;"There are no areas in the world where food allergy is declining"&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
In Australia 16% of children had sensitization to egg and half had a positive challenge. Highest in the world. People of Asian genetic background appear to have a higher propensity to atopy/food allergy, especially in Westernized countries.&lt;br /&gt;
&lt;br /&gt;
There is an Interdisciplinary, international network studying inflammatory diseases: In-FLAME.&lt;br /&gt;
&lt;br /&gt;
Early life inflammation leads to increased C-reactive protein (CRP) during pregnancy and early life associated with inflammatory disease. In utero exposures may drive predisposition to sustained inflammatory responses.&lt;br /&gt;
&lt;br /&gt;
Affluence --&amp;gt; Low microbial environments --&amp;gt; increased baseline inflammation --&amp;gt; sustained inflammatory response --&amp;gt; increased Non-communicable diseases (NCD).&lt;br /&gt;
&lt;br /&gt;
Allergy itself further drives ongoing inflammation and can increase risk of other NCD's, e.g. cardiovascular disease.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Biodiversity in GI tract may be protective&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Has eradicating H. pylori increased risk of obesity, insulin resistance, autoimmunity, allergy, asthma? Modern diets alter the gastrointestinal microbiome,&amp;nbsp;thus increasing&amp;nbsp;risk of NCD. Can pre/probiotics help modulate this risk?&lt;br /&gt;
&lt;br /&gt;
Antibiotics from agricultural products (even low doses) can alter human gut flora and increase risk of metabolic disease. &lt;br /&gt;
&lt;br /&gt;
Smoking and pollutants, diet, microbial exposures can also modulate gene expression. There are incredibly intertwined relationship of genetics and environment.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;What can we do to induce tolerance in early life?&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Exercise, stress-reduction during pregnancy, low-inflammatory diet, microbial biodiversity are all potential measures.&lt;br /&gt;
&lt;br /&gt;
A BMJ fish oil study in pregnant women showed a small but stat significant reduction in AD and egg allergy.&lt;br /&gt;
&lt;br /&gt;
A Cochrane review of the use of probiotics for allergic disease showed improvement in atopic dermatitis but no other allergic disease.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Gene-environment interaction&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Harald Renz presented on gene-environment interaction in chronic inflammatory disease.&lt;br /&gt;
&lt;br /&gt;
Pre- and post-natal environment provides an opportunity for early immuno-education and programming. Having older siblings, early day care, traditional farming lifestyle are all associated with lower risk of asthma.&lt;br /&gt;
&lt;br /&gt;
Acinetobacter lowfii, Staph sciuri, Lactococcus lactis, Lactobacillus GG, and others may reduce asthma risk. &lt;br /&gt;
&lt;br /&gt;
The microbial "fingerprint" is unique in various organ systems. Intestinal and pulmonary microbiomes are linked. &lt;br /&gt;
&lt;br /&gt;
C-section is associated with a different microbiome for baby than vaginal delivery. It is associated with increased risk of asthma, atopy. Someone in audience mentioned they're aware of study where children born by C/S and having their Mom's vaginal secretions given to them.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Epigenetics&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
In each cell, only about 20K of 100K genes will actually be expressed - determined by chromatin packaging. If the chromatin is packaged in the "wrong way", celles will get aberrant gene expression that lead to disease states in those cells. If chromatin is heavily condensed you won't see gene expression - histones and methyl groups influence this.&lt;br /&gt;
&lt;br /&gt;
We used to think that 98% of genome is "junk" DNA - we now know this junk DNA contains important determinants of gene expression. Epigenetics can explain population changes over time that would not be explained by things like Darwinian theory. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Genome is static; Epigenetic is dynamic - subject to continuous "editing"&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
We were all born with a genetic "script" that can be modified with environmental exposures - can edit our script. Developmental plasticity may explain early origins of human disease such as allergy and asthma. Exposure to synthetic chemicals, pollutants and dietary choices can influence disease development via epigenetic alterations. &lt;br /&gt;
&lt;br /&gt;
Maternal exposure to polycyclic aromatic hydrocarbons was associated with childhood wheeze in Ho's study through gene hypermethylation. We need to think about exposures as groups not just individually - Ho calls this an &lt;b&gt;"Exposisome"&lt;/b&gt;.&lt;br /&gt;
&lt;br /&gt;
Firefighters are examined because of frequent chemical exposures. They've studied a gene that gets modified the longer they work. &lt;br /&gt;
&lt;br /&gt;
There are several ways through which epigenetics works to affect gene expression - non coding RNAs, DNA methylation, histone acetylation or modification. DNA methylation leads to gene silencing. Prenatal tobacco smoke exposure affects global and gene specific DNA methylation. &lt;br /&gt;
&lt;br /&gt;
Hypomethylation increases with age - &lt;b&gt;"Epigenetic Drift"&lt;/b&gt;. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Biome and Immune Interactions&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Andrew Kau presented on sorting out microbiota, diet and immune interactions: lessons from malnutrition.&lt;br /&gt;
&lt;br /&gt;
Human microbiota: we are all living with a large variety of microorganisms. Skin, gut, sinopulmonary tract, etc. Nutritional value of food is shaped by microbiota.&lt;br /&gt;
&lt;br /&gt;
16S rRNA gene is characterized as powerful method of classifying different bacteria, using PCR amplification.&lt;br /&gt;
&lt;br /&gt;
Enterobactericeae colonization in small intestine is associated with environmental enteropathy. Akkermansia muciniphilia is a microbe which may be protective against inflammatory bowel disease.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Microbiome &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Jeffrey Gordon, MD presented on Microbiome in Health and Disease. The Gordon Lab URL: &lt;a href="http://gordonlab.wustl.edu/"&gt;http://gordonlab.wustl.edu&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;The Gut Microbiome is like “Dining with Trillions of Fascinating Friends.”&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Microbiota = collection of microorganisms. Microbiome = collection of genes present in the microbiota.&lt;br /&gt;
&lt;br /&gt;
Our microbiota varies as a function of lifestyle. Therefore, it can only be understood in the context in which we live. By mid-century, world population will be ~9 billion. How can we feed all these people in a healthy way? Can studying the gut microbiome help us identify which foods are compatible with long-term health? &lt;br /&gt;
&lt;br /&gt;
We begin to develop microbial colonization at birth, and it transitions to the "adult" pattern in the first 3 years of life. &lt;br /&gt;
&lt;br /&gt;
In industrialized societies, there is less biodiversity within the gut microbiome than in agrarian societies.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Maternal vitamin D and asthma risk &lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Maria Magnus presented on maternal vitamin D and asthma risk.&lt;br /&gt;
&lt;br /&gt;
1,25-dihydroxy vitamin D is the active form of Vitamin D. Maternal 25(OH)D increased with age and education, and varied by month of sampling. There was an inverse association between maternal vitamin D and asthma/LRTI in children.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Home environment&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Use of forced air HVAC and incidence of asthma trend up together. VOC's are more predominant indoors, as houses are built to be so airtight nowadays. Tighter homes estimated to increase asthma symptoms by 20%.&lt;br /&gt;
&lt;br /&gt;
Damp indoor spaces are a major risk factor due to dust mite, mold and pests. Mold in damp environments is associated with the development and severity of asthma. &lt;br /&gt;
&lt;br /&gt;
Installation of insulated windows is associated with increased levels of house dust mite. &lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Bisphenol A (BPA)&amp;nbsp;&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
BPA is found in most types of plastics and is an estrogen mimetic and 93% of Americans have detectable urinary BPA.&lt;br /&gt;
&lt;br /&gt;
BPA (bisphenol A) may increase risk of CAD, brain tumor, miscarriage, PCOS. Approximately 90% of population is exposed. &lt;br /&gt;
&lt;br /&gt;
"BPA-free" generally means that Bisphenol S (BPS) has been substituted. Some studies suggest BPS may be even worse than BPA.&lt;br /&gt;
&lt;br /&gt;
&lt;b&gt;Allergists are on Twitter - follow them&lt;/b&gt;&lt;br /&gt;
&lt;br /&gt;
Allergists increased Twitter use 470% in one year - 25 allergists reached 250,000 individuals from the 2012 #AAAAI meeting (&lt;a href="http://allergynotes.blogspot.com/2013/02/allergists-increase-twitter-use-470-in.html"&gt;see the references here&lt;/a&gt;). This summary was compiled from some of the tweets posted by the following allergists:&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://twitter.com/allergistmommy"&gt;https://twitter.com/allergistmommy&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/DrAnneEllis"&gt;https://twitter.com/DrAnneEllis&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/IgECPD"&gt;https://twitter.com/IgECPD&lt;/a&gt;&lt;br /&gt;
&lt;a href="https://twitter.com/mrathkopf"&gt;https://twitter.com/mrathkopf&lt;/a&gt;&lt;br /&gt;
&lt;br /&gt;
&lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;This is a list of the allergists&lt;/a&gt; who used Twitter to post updates from the 2013 #AAAAI meeting. &lt;a href="https://docs.google.com/spreadsheet/ccc?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;usp=sharing" target="_blank"&gt;The list is open for edit&lt;/a&gt;, please feel free to add your own info. &lt;br /&gt;
&lt;br /&gt;
&lt;iframe frameborder="0" height="300" src="https://docs.google.com/spreadsheet/pub?key=0Ajlo36xvP22vdFpJWENWWFF5b1dZcnFIbmZCbDlQNXc&amp;amp;single=true&amp;amp;gid=0&amp;amp;output=html&amp;amp;widget=true" width="500"&gt;&lt;/iframe&gt;&lt;br /&gt;
&lt;br /&gt;
I would strongly encourage you to post updates on Twitter from the CME conferences that you are planning to attend in the future. Here is how to do it: &lt;a href="http://www.worldallergy.org/juniormembers/news/index.php?contentid=781"&gt;Twitter for Physicians: How to use Twitter to keep track of the latest news and scientific meetings, and share information with colleagues and patients&lt;/a&gt;.&lt;br /&gt;
&lt;br /&gt;
Disclaimer: The text was edited, modified, and added to by me. This is one of a series of posts that will be published during the next few weeks.&lt;br /&gt;
&lt;br /&gt;
Comments from Twitter:&lt;br /&gt;
&lt;br /&gt;
Dr John Weiner @AllergyNet: Good info here. Thank you MT @Allergy: Microbiome and Allergy - Twitter summary from 2013 #AAAAI meeting bit.ly/WwOzf9&lt;br /&gt;
&lt;br /&gt;
Airmid Healthgroup @AirmidHealth: Twitter summary 2013 #AAAAI via @Allergy Mold in damp environments associated with asthma development &amp; severity goo.gl/fb/2FQd8&lt;div class="blogger-post-footer"&gt;&lt;p&gt;   &lt;/p&gt;

Posted at &lt;a href="http://allergynotes.blogspot.com/"&gt;Allergy Notes&lt;/a&gt;. Stay updated and &lt;a href="http://feeds.feedburner.com/AllergyNotes"&gt;subscribe&lt;/a&gt;, follow us on &lt;a href="http://twitter.com/Allergy"&gt;Twitter&lt;/a&gt; and connect on &lt;a href="http://www.facebook.com/AllergyNotes"&gt;Facebook&lt;/a&gt;.&lt;/div&gt;&lt;img src="http://feeds.feedburner.com/~r/AllergyNotes/~4/wqPKbX0bS8M" height="1" width="1"/&gt;</content><link rel="replies" type="application/atom+xml" href="http://allergynotes.blogspot.com/feeds/5370625647267075630/comments/default" title="Post Comments" /><link rel="replies" type="text/html" href="http://allergynotes.blogspot.com/2013/03/early-life-environment-and-microbiome.html#comment-form" title="1 Comments" /><link rel="edit" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5370625647267075630?v=2" /><link rel="self" type="application/atom+xml" href="http://www.blogger.com/feeds/2057269305378114997/posts/default/5370625647267075630?v=2" /><link rel="alternate" type="text/html" href="http://feedproxy.google.com/~r/AllergyNotes/~3/wqPKbX0bS8M/early-life-environment-and-microbiome.html" title="Early life environment and microbiome influence on allergic diseases - Twitter summary from 2013 #AAAAI meeting" /><author><name>Ves Dimov, M.D.</name><uri>https://plus.google.com/110859855629071891085</uri><email>noreply@blogger.com</email><gd:image rel="http://schemas.google.com/g/2005#thumbnail" width="32" height="32" src="//lh3.googleusercontent.com/-gR8nbD9QdZc/AAAAAAAAAAI/AAAAAAABgMw/HuD5e8jlvpE/s512-c/photo.jpg" /></author><thr:total>1</thr:total><feedburner:origLink>http://allergynotes.blogspot.com/2013/03/early-life-environment-and-microbiome.html</feedburner:origLink></entry></feed>
